US20010029328A1 - Readable probe array for in-vivo use - Google Patents
Readable probe array for in-vivo use Download PDFInfo
- Publication number
- US20010029328A1 US20010029328A1 US09/881,283 US88128301A US2001029328A1 US 20010029328 A1 US20010029328 A1 US 20010029328A1 US 88128301 A US88128301 A US 88128301A US 2001029328 A1 US2001029328 A1 US 2001029328A1
- Authority
- US
- United States
- Prior art keywords
- probe
- detector
- lysing
- array
- lumen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000523 sample Substances 0.000 title claims description 62
- 238000001727 in vivo Methods 0.000 title abstract description 6
- 230000005284 excitation Effects 0.000 claims abstract description 15
- 239000000463 material Substances 0.000 claims description 30
- 230000002934 lysing effect Effects 0.000 claims description 19
- 239000000758 substrate Substances 0.000 claims description 12
- 230000001225 therapeutic effect Effects 0.000 claims description 11
- 239000003153 chemical reaction reagent Substances 0.000 claims description 9
- 239000003814 drug Substances 0.000 claims description 8
- 230000003287 optical effect Effects 0.000 claims description 8
- 239000012491 analyte Substances 0.000 claims description 7
- 238000001514 detection method Methods 0.000 claims description 7
- 108090000623 proteins and genes Proteins 0.000 claims description 7
- 239000004033 plastic Substances 0.000 claims description 6
- 229920003023 plastic Polymers 0.000 claims description 6
- 229940079593 drug Drugs 0.000 claims description 5
- 210000000170 cell membrane Anatomy 0.000 claims description 4
- 102000004169 proteins and genes Human genes 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 3
- 108091034117 Oligonucleotide Proteins 0.000 claims description 2
- 238000004873 anchoring Methods 0.000 claims description 2
- 238000002399 angioplasty Methods 0.000 claims description 2
- 238000001802 infusion Methods 0.000 claims description 2
- 238000002604 ultrasonography Methods 0.000 claims description 2
- 239000000976 ink Substances 0.000 claims 6
- 239000002861 polymer material Substances 0.000 claims 1
- 239000000126 substance Substances 0.000 abstract description 6
- 201000010099 disease Diseases 0.000 abstract description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 3
- 230000002068 genetic effect Effects 0.000 abstract description 2
- 238000012544 monitoring process Methods 0.000 abstract description 2
- 230000007613 environmental effect Effects 0.000 abstract 1
- 230000010354 integration Effects 0.000 abstract 1
- 230000002503 metabolic effect Effects 0.000 abstract 1
- 230000037361 pathway Effects 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 description 13
- 238000004458 analytical method Methods 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 8
- 239000007850 fluorescent dye Substances 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 239000007943 implant Substances 0.000 description 5
- 230000008901 benefit Effects 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 238000003384 imaging method Methods 0.000 description 3
- -1 regents Substances 0.000 description 3
- 229910052710 silicon Inorganic materials 0.000 description 3
- 239000010703 silicon Substances 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 230000009471 action Effects 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000007639 printing Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 241000242764 Aequorea victoria Species 0.000 description 1
- IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 1
- CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 241000242583 Scyphozoa Species 0.000 description 1
- 235000005811 Viola adunca Nutrition 0.000 description 1
- 240000009038 Viola odorata Species 0.000 description 1
- 235000013487 Viola odorata Nutrition 0.000 description 1
- 235000002254 Viola papilionacea Nutrition 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- SKTQUNFBPUMFOT-UHFFFAOYSA-N carbamimidoylazanium;dioxido-oxo-sulfanylidene-$l^{6}-sulfane Chemical compound NC([NH3+])=N.NC([NH3+])=N.[O-]S([O-])(=O)=S SKTQUNFBPUMFOT-UHFFFAOYSA-N 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000003398 denaturant Substances 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 210000005003 heart tissue Anatomy 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 229940109328 photofrin Drugs 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 239000005060 rubber Substances 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 239000008279 sol Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0075—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0082—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes
- A61B5/0084—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes for introduction into the body, e.g. by catheters
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/645—Specially adapted constructive features of fluorimeters
- G01N21/6452—Individual samples arranged in a regular 2D-array, e.g. multiwell plates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0071—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by measuring fluorescence emission
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0082—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes
- A61B5/0084—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes for introduction into the body, e.g. by catheters
- A61B5/0086—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes for introduction into the body, e.g. by catheters using infrared radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0093—Detecting, measuring or recording by applying one single type of energy and measuring its conversion into another type of energy
- A61B5/0097—Detecting, measuring or recording by applying one single type of energy and measuring its conversion into another type of energy by applying acoustic waves and detecting light, i.e. acoustooptic measurements
Definitions
- the present invention performs specific detection and analysis of biological analytes in vivo using a simplified, low cost set of components.
- the small size and simplified operation allows the entire device to be housed in a catheter.
- the device consists of a housing, a light excitation source, and detector and at least one fluorescent labeled probe material on a substrate that is exposed to the tissue of the body.
- the excitation source may be directed at the substrate carrying the probe, or may be a conductor of the excitation energy.
- Other embodiments include the use of a lumen to introduce a lysing agent or energy to the area of interest.
- the lysing agent or energy may be an ultrasonic transducer capable of rupturing cell membranes through the use of a brief burst of ultrasonic energy.
- a lysing system is used in which pressurization and evacuation of the sample via the lumen adjacent to the probe array creates a pressure capable of rupturing the cell membrane.
- Each of the probes may be read by application of electrical current to the excitation source and by detecting the presence or absence of signal via the probe sensor.
- the probe sensor may be a photodiode that is responsive to light emitted by the fluorescent probe material. Two probes may be mixed and read by two sensors if the spectrum is sufficiently separated. A ratio can then be obtained to facilitate analysis.
- a normalizing patch may be adjacent to provide a reference signal, thereby simplifying the calibration of the instrument.
- FIG. 1 is a planar view of a probe array containing a multiplicity of fluorescent probes on its surface.
- FIG. 1A is a cross sectional view of the probe array of FIG. 1.
- FIG. 1B is a cross sectional view of a sheet of material carrying a probe array.
- FIG. 2 is a cross-sectional view of a readable polydeoxynucleotide array module. (RPAM)
- FIG. 2A is a block diagram of the readable polydeoxynucleotide array module and system.
- FIG. 3 is a cross sectional view of an interventional device carrying the readable polydeoxynucleotide array module.
- FIG. 4 is a cross sectional view of an interventional device fitted with a lysing core.
- FIG. 5 is a side view of a secondary insertable device having a tip and a multifilar shaft.
- FIG. 6 is a cross sectional view of a hollow needle carrying the readable polydeoxynucleotide array module equipped insertable appliance.
- FIG. 1 the planar view of a probe array 11 is shown as a grid-like array with a plurality of chambers 13 arranged to have separators 15 within a frame 17 .
- the frame 17 may be a small injection-molded component made of a plastic such as polystyrene or a molded material such as glass.
- the separators 15 may be molded integrally to the frame 17 or may be separate elements placed within it.
- the overall dimensions of the frame 17 may be small. Typical dimensions are less than 1 mm by 1 mm.
- FIG. 1A is a cross sectional view of the probe array 11
- the aforementioned separators 15 are effective to separate a fluorescent probe material 21 that may have different characteristics from an adjacent fluorescent probe material 23 .
- Probe materials 21 and 23 are generally deposited in a thin layer on top of a substrate, in this case the material of the frame 17 .
- the frame 17 may be made of a foraminous material or a partly foraminous substance such as sol gel (not shown).
- the probe materials may be incorporated into the substrate, which may be a flat surface which allows ink printing processes to be used to deposit the probe array materials at high speeds and at low cost.
- Probe materials generally are engineered molecular materials that are designed to have an affinity to one or more constituents that may be expected to be found in the tissue, fluid or chemical mix to be analyzed. These probe materials may be made sensitive to specific genes or gene segments through complimentary genetic indicators that have been designed to fluoresce or change color, as observed by the naked eye or by spectrographic analysis methods, when they are linked to a molecule to which they have affinity. A large number of different types and combinations of optically readable probes are being manufactured today that have specific affinity to one or more genes, proteins or other chemicals.
- the present invention contemplates the use of two classes of probes: (i) protein sensitive probes, such as GFP (green fluorescent probe) from the jellyfish Aequorea Victoria ; and (ii) modified ohigonucleotide probes that are fluorogenic, such as those manufactured by Synthegen LLC, Houston, Tex. 77042. Additional probes suited for use in the present invention are available from Midland Certified Reagent Company, Midland, Tex. 79701, and Transbio Corp., Baltimore, Md. 21220. Typically these probes must be used in vitro due to either their lack of biocompatability or because they must be used in conjunction with aggressive reagents that are toxic to cells.
- protein sensitive probes such as GFP (green fluorescent probe) from the jellyfish Aequorea Victoria
- modified ohigonucleotide probes that are fluorogenic, such as those manufactured by Synthegen LLC, Houston, Tex. 77042.
- Additional probes suited for use in the present invention are available from Midland Certified
- a sheet of plastic material 33 may have lines 35 made of probe filled ink printed in any arrangement that may be produced with printing methods. More than one type of probe-filled ink may be used to produce various patterns and arrangements, including overlapping patterns (not shown).
- the ink pattern lines 35 may be protected with a topcoat 37 which may be made of a dissolvable gel such as ordinary gelatin, or another material such as a soluble or even a waterproof polymer that only dissolves and provides access to the probe material in the probe-filled ink in lines 35 after the application of a solvent.
- the arrangement of the sensitive areas by this process allows the probe materials to be applied to a variety of surfaces and substrates, including medical devices such as needles, trocars, forceps, catheters, guidewires, implants and prostheses, in an inexpensive and reliable manner.
- RPAM readable polydeoxynucleotide array module
- FIG. 2 is a cross sectional view of a readable polydeoxynucleotide array module (RPAM) 41 , the probe array 11 may be positioned adjacent to a spectrometer module that is encapsulated in an at least partly transparent housing 45 .
- the probe array 11 may be cemented to the side, top or other area within a spectrometer module 43 with an optical cement (not shown), or by a solvent bond line 47 which allows two plastics to be fused through partial melting.
- a spectrometer module suitable for use in this invention has been described in pending U.S. patent application Ser. No 08/898,604, the entire disclosure of which is incorporated by reference herein.
- the spectrometer module used in the present invention includes a light source and a light detector for placement inside a body such that optical conduits are not necessary to deliver light signals to and from the RPAM inside the body.
- the miniature spectrometer includes the light source and one or more light detectors.
- the light source illuminates a tissue region and the light detectors detect optical properties of the illuminated tissue by measuring modified light signals.
- the light detectors convert optical signals to electrical signals such that one or more electrical wires placed inside an interventional device can deliver the electrical signals from the RPAM to a signal display or a microprocessor.
- an optically transparent tip encapsulates a spectrometer.
- the tip is shaped to optimize tissue contact and optical transmission.
- the tip encapsulating the spectrometer is disposed at a distal end of an interventional device.
- the tip may be coated with a material to improve light transmission.
- the tip may include at least one fluid channel, which is in communication with a lumen inside the interventional device, to deliver a fluid to a tissue region.
- the spectrometer may also include a light source and the light detectors formed on a single substrate.
- the light source may be a light emitting diode and the light detectors may be a photodiode comprising multiple channels, where both devices are formed on a silicon substrate.
- the light detector can include multiple channels to detect light emission at multiple wavelengths.
- probe array 11 may be integrally molded onto the surface of the spectrometer module 43 creating a somewhat simplified one-piece unit which may provide processing advantages in high speed production environments where parts counts are intentionally kept low to minimize stock and therefore reduce cost of fabrication and assembly. Injection molding or casting of the components is effective to produce miniature components that correspond in size to conventional silicon-based integrated circuit scale. Therefore it should be appreciated that the RPAM may be small, e.g., about the size of a miniature electronic component such as a surface mount device. Such devices include packaging, leads, and other components, and may be obtainable in size ranges of less than 1 mm in length.
- Such devices may typically be configured in the range from about 0.5 mm to about 3 mm to produce small, useful devices for in vivo use.
- the RPAM 41 may also have printable surfaces according to the construction of alternative probe array configurations as described in FIG. 1A and FIG. 1B, if desired.
- the internal components of the RPAM consist of a substrate material 49 such as silicon upon which a light-emitting diode light source 51 is mounted with power lead 53 attached to one of terminals 55 .
- Various colors and types of diode light sources may be used, including those now available that emit light in the infrared, the red, the yellow, the green, the blue, and the blue-violet regions.
- a working range of RPAM excitation wavelengths is from about 1100 nanometers to about 250 nanometers and may comprise monochromatic, bichromatic or broadband emissions.
- the exit aperture 57 is positioned to illuminate movable mirror 59 which is bonded to piezoelectric stack actuator 61 .
- Empowerment of the stack actuator 61 is effective to direct light emission from diode light source 51 to one or more chambers 13 .
- Light emission from the probe materials 21 is picked up by one or more light detectors 63 through filters 65 . Signals from the detectors 63 are brought out from the RPAM through other terminals 55 .
- FIG. 2A the operation of the RPAM is depicted in block diagram form as follows: Light is generated and directed from light source 51 and directed at one or more of chambers 13 by mirror 59 , which impinges upon at least one probe material 21 . Fluorescence or other secondary light generated by the action of the light energy upon the probe material causes a second emission that may be detected by one or more light detectors 63 after passing through a bandpass filter 65 . The signal may be amplified and/or conditioned by one or more amplifier stages 64 .
- Filters 65 allow the system to discriminate between various secondary light emission wavelengths, and signals from said light detectors 63 may be synchronized with the operation of light source 51 so that at any given time there is a known relationship between the particular probe that is illuminated and its response as detected by the light detectors.
- the timing and relationship of the light generating and light detecting event and the spatial position of the mirror 59 are controlled by CPU 71 and sent to the components via control lines 73 .
- the data obtained may be stored or presented in a display device or other therapeutic device which can be a graphical display, a television monitor, printout or drug delivery pump, interventional device, motor or actuator, etc. Accordingly, this apparatus may effectively scan or read a plurality of probe materials in a repeatable, fast and controllable manner, and the information read may be stored, displayed, or used to initiate another action such as a therapeutic application of a drug, or control of a motor.
- the bandpass filter system of detecting one or more light wavelengths for this purpose is basic and that more complex schemes could be employed by those of ordinary skill in the art.
- Such schemes may include, without limitation; light wavelength detection systems comprising gratings, graduated filters, heterodyne detection, acousto-optic tunable filtering, and other light detectors that effectively provide and amplitude and frequency responsive signal.
- a diffraction grating (not shown), for instance, may be attached to movable mirror 59 to provide spatial and chromatic control simultaneously.
- FIG. 3 the cross sectional view of an interventional device incorporating the spectrometer and probe still referred to here as RPAM 41 ; there is a body-insertable appliance 81 such as a catheter which may have a distal end and a proximal end and may consist of a plastic, rubber or metal material that is generally elongated in shape, has a small cross-section allowing it to pass easily through the body, and has one or more lumens or conduits which may extend through the length of the device. Shown in FIG. 3 is a device having three lumens although a greater or lesser number of lumens may be used depending upon the application for which the device is intended.
- a body-insertable appliance 81 such as a catheter which may have a distal end and a proximal end and may consist of a plastic, rubber or metal material that is generally elongated in shape, has a small cross-section allowing it to pass easily through the body, and has one or more lumens or conduits which may
- the main lumen 83 is relatively large and is used to deliver a drug, a reagent, or a device to or beyond the distal tip 89 .
- Suction lumen 85 is useful for drawing biological fluids, tissue or other materials into proximity with the RPAM 41 , where the material can be analyzed.
- Signal wires 74 may extend to an external controller (not shown) or to a CPU, pump, motor or other controller as shown in FIG. 2A, 75.
- infusion lumen 87 may provide additional fluids, regents, drugs, wires or appliances that may be useful to the procedure.
- additional reagents can be introduced to facilitate analysis.
- additional reagents can include: denaturants, such as guanidinium thiosulfate; buffers, such as Tris-Cl; detergents, such as SDS; chelators, such as EDTA; enzymes, such as proteinases and/or DNAases; and other reagents known to those of ordinary skill in the art which may be appropriate to the particular analysis to be carried out using the apparatus of the present invention.
- FIG. 4 a cross sectional view of an interventional device such as a body insertable appliance 81 fitted with a lysing core 101 , is shown.
- the lysing core 101 utilizes mechanical motion to disrupt cells in order to make the cell contents available for analysis by the RPAM (not shown).
- the use of a lysing device in conjunction with the RPAM system eliminates the need for potentially toxic reagents that are commonly used to open cells in vitro.
- the lysing head 105 consists here of a more or less hemispherical component that may be comprised of a metal or plastic, which is mounted at the distal end of a driveshaft 103 .
- Such driveshafts are well known for their ability to deliver torque and rotary motion from a proximal motor 107 or by hand control.
- motor 107 is one of a class of components shown in FIG. 2A as 75 which may be controlled by system CPU 71 , also shown in FIG. 2A.
- Numerous other lysing devices are known that may abrade, disrupt, dissolve, pressurize, vacuum, cavitate or otherwise apply mechanical forces to a cell or cells that is effective to disrupt the cell and make its contents available for analysis. It should be pointed out that such damage to cells is usually minimized to avoid permanent damage to the organ, vessel, duct or tissue being tested.
- the lysing head 105 need not be relatively large and may be made small enough so that it may easily pass through the device from the proximal end so that another device or implant may be inserted, if needed, through the same large lumen 83 .
- Such an implant may be a solid or porous, foraminous or dissolvable seed, implant, stent, gel or the like, which may carry therapeutic agents to a particular site in the body.
- This system provides the advantage that local conditions can be determined through use of the polydeoxynucleotide readable array (afforded by the construction of the RPAM device as described herein), and therefore, better and more precise application of appropriate medicaments, drugs, therapeutic genetically based substances, etc., is facilitated.
- FIG. 5 is a side view of a secondary insertable device 111 comprising a rotary, multifilar flexible driveshaft 112 having a therapeutic tip 113 terminating in an anchoring device 115 shown as a screw form capable of being screwed into tissue until separable joint 117 breaks, after which the remaining part of insertable device 111 may be withdrawn.
- Driveshaft 112 may be hollow, to allow tether 119 to remain attached to therapeutic tip 113 .
- Tether material may be constructed of a wire to allow the sending and receiving of an electrical signal, or may simply be used as a retrieval device to retrieve any portion of the therapeutic tip that may remain after the need for it is over.
- FIG. 6 is a cross sectional view of a hollow needle 121 carrying the RPAM insertable appliance 81 .
- the advantage of a needle is that it allows the introduction of the RPAM into portions of the body where there is no natural passageway. This method allows the user to position the distal tip of the lysing head 105 in various positions with respect to the sharp needle tip 106 .
- the needle may be of stainless steel and may be inserted into body tissue such as muscle, breast, prostate, or cardiac tissue. The needle may be left in place, and the RPAM withdrawn temporarily to allow another appliance (not shown) to be introduced.
- Other carrying devices may include guidewires, balloon catheters, ultrasound catheters with both imaging or non-imaging, and rotatable or array configurations, introducer sheaths, balloon angioplasty catheters for use in the blood vessels of the heart, the extremities, and the vascular system, atherectomy catheters, and many other types of interventional devices, as well as intraoperative devices.
- the device of the invention may be used anywhere there is the need for fast, precise localized detection and analysis of nucleotides, proteins or the like, either for diagnostic purposes, or to guide therapy which itself may be made more localized, and therefore site-specific. Such uses are economical and have less impact on surrounding tissue that is free of disease.
- the invention allows use of any agent that may change color as a result of the application of a local chemical to be read and includes without limitation such agents as litmus, photodynamic therapeutic agents such as photofrin, fluorescent agents or dyes, staining dyes, luciferin, etc.
- the present invention permits analysis in a real time fashion without the need to remove and transport tissue specimens for later analysis.
Abstract
Description
- Polydeoxynucleotide and oligonucleotide sequencing with laboratory-based instruments has become inexpensive and reliable due to the variety and availability of complimentary fluorescent labeled target sequences. These fluorescent labeled probes may be specially tailored to hybridize with genomic DNA segments and form base pair matches that can accurately detect the presence of inherited genetic disorders or native-cell mutations. Under excitation light in the visible or UV range, the associated fluorescent marker attached to the probe emits a secondary emission which may be detected by a charge-coupled device
- However, current techniques require the use of specialized reagents and additional processing to separate the cell wall and other components before analysis. The analyte is removed and introduced into an assay chamber for analysis. The chambers are housed in portable or tabletop analytic instruments that typically contain an excitation source, detection sensors, spatial reading or imaging devices, and archiving capabilities. These systems are expensive and require that tissue samples be processed prior to use. The biggest drawback to these types of systems is their inherent inability to perform fast, localized reading of array probes in a convenient, and repeatable manner in vivo. In vivo monitoring and detection of changes to the human body in response to therapy is needed to expedite trials and to monitor results from therapy, and would allow doctors to treat serious diseases such as cancer safely in a more effective and less costly manner.
- The present invention performs specific detection and analysis of biological analytes in vivo using a simplified, low cost set of components. In one embodiment the small size and simplified operation allows the entire device to be housed in a catheter. In one aspect, the device consists of a housing, a light excitation source, and detector and at least one fluorescent labeled probe material on a substrate that is exposed to the tissue of the body. The excitation source may be directed at the substrate carrying the probe, or may be a conductor of the excitation energy. Other embodiments include the use of a lumen to introduce a lysing agent or energy to the area of interest. The lysing agent or energy may be an ultrasonic transducer capable of rupturing cell membranes through the use of a brief burst of ultrasonic energy. In another aspect, a lysing system is used in which pressurization and evacuation of the sample via the lumen adjacent to the probe array creates a pressure capable of rupturing the cell membrane. Each of the probes may be read by application of electrical current to the excitation source and by detecting the presence or absence of signal via the probe sensor. The probe sensor may be a photodiode that is responsive to light emitted by the fluorescent probe material. Two probes may be mixed and read by two sensors if the spectrum is sufficiently separated. A ratio can then be obtained to facilitate analysis. In another embodiment, a normalizing patch may be adjacent to provide a reference signal, thereby simplifying the calibration of the instrument.
- FIG. 1 is a planar view of a probe array containing a multiplicity of fluorescent probes on its surface.
- FIG. 1A is a cross sectional view of the probe array of FIG. 1.
- FIG. 1B is a cross sectional view of a sheet of material carrying a probe array.
- FIG. 2 is a cross-sectional view of a readable polydeoxynucleotide array module. (RPAM)
- FIG. 2A is a block diagram of the readable polydeoxynucleotide array module and system.
- FIG. 3 is a cross sectional view of an interventional device carrying the readable polydeoxynucleotide array module.
- FIG. 4 is a cross sectional view of an interventional device fitted with a lysing core.
- FIG. 5 is a side view of a secondary insertable device having a tip and a multifilar shaft.
- FIG. 6 is a cross sectional view of a hollow needle carrying the readable polydeoxynucleotide array module equipped insertable appliance.
- Referring now to FIG. 1, the planar view of a
probe array 11 is shown as a grid-like array with a plurality ofchambers 13 arranged to haveseparators 15 within a frame 17. The frame 17 may be a small injection-molded component made of a plastic such as polystyrene or a molded material such as glass. Theseparators 15 may be molded integrally to the frame 17 or may be separate elements placed within it. The overall dimensions of the frame 17 may be small. Typical dimensions are less than 1 mm by 1 mm. - Referring now to FIG. 1A, which is a cross sectional view of the
probe array 11, theaforementioned separators 15 are effective to separate afluorescent probe material 21 that may have different characteristics from an adjacentfluorescent probe material 23.Probe materials - Probe materials generally are engineered molecular materials that are designed to have an affinity to one or more constituents that may be expected to be found in the tissue, fluid or chemical mix to be analyzed. These probe materials may be made sensitive to specific genes or gene segments through complimentary genetic indicators that have been designed to fluoresce or change color, as observed by the naked eye or by spectrographic analysis methods, when they are linked to a molecule to which they have affinity. A large number of different types and combinations of optically readable probes are being manufactured today that have specific affinity to one or more genes, proteins or other chemicals. In preferred embodiments, the present invention contemplates the use of two classes of probes: (i) protein sensitive probes, such as GFP (green fluorescent probe) from the jellyfishAequorea Victoria; and (ii) modified ohigonucleotide probes that are fluorogenic, such as those manufactured by Synthegen LLC, Houston, Tex. 77042. Additional probes suited for use in the present invention are available from Midland Certified Reagent Company, Midland, Tex. 79701, and Transbio Corp., Baltimore, Md. 21220. Typically these probes must be used in vitro due to either their lack of biocompatability or because they must be used in conjunction with aggressive reagents that are toxic to cells.
- Various methods and configurations may be used to deposit or arrange probe locations and positions in an array or singly. For instance, a sheet of
plastic material 33, as shown in FIG. 1B, may havelines 35 made of probe filled ink printed in any arrangement that may be produced with printing methods. More than one type of probe-filled ink may be used to produce various patterns and arrangements, including overlapping patterns (not shown). Theink pattern lines 35 may be protected with atopcoat 37 which may be made of a dissolvable gel such as ordinary gelatin, or another material such as a soluble or even a waterproof polymer that only dissolves and provides access to the probe material in the probe-filled ink inlines 35 after the application of a solvent. The arrangement of the sensitive areas by this process allows the probe materials to be applied to a variety of surfaces and substrates, including medical devices such as needles, trocars, forceps, catheters, guidewires, implants and prostheses, in an inexpensive and reliable manner. - The following discussion and description of the present invention is directed to a readable polydeoxynucleotide array module (RPAM). However, those skilled in the art will appreciate that the present invention and specific embodiments described below may be utilized with any number of probe arrays and the RPAM described here is provided as only one, non-limiting, example.
- Referring now to FIG. 2, which is a cross sectional view of a readable polydeoxynucleotide array module (RPAM)41, the
probe array 11 may be positioned adjacent to a spectrometer module that is encapsulated in an at least partlytransparent housing 45. Theprobe array 11 may be cemented to the side, top or other area within aspectrometer module 43 with an optical cement (not shown), or by asolvent bond line 47 which allows two plastics to be fused through partial melting. A spectrometer module suitable for use in this invention has been described in pending U.S. patent application Ser. No 08/898,604, the entire disclosure of which is incorporated by reference herein. - Specifically, the spectrometer module used in the present invention includes a light source and a light detector for placement inside a body such that optical conduits are not necessary to deliver light signals to and from the RPAM inside the body. The miniature spectrometer includes the light source and one or more light detectors. The light source illuminates a tissue region and the light detectors detect optical properties of the illuminated tissue by measuring modified light signals. The light detectors convert optical signals to electrical signals such that one or more electrical wires placed inside an interventional device can deliver the electrical signals from the RPAM to a signal display or a microprocessor.
- The light source and the light detectors are energized by an external power supply through electrical wires. In another embodiment, an optically transparent tip encapsulates a spectrometer. The tip is shaped to optimize tissue contact and optical transmission. The tip encapsulating the spectrometer is disposed at a distal end of an interventional device. The tip may be coated with a material to improve light transmission. The tip may include at least one fluid channel, which is in communication with a lumen inside the interventional device, to deliver a fluid to a tissue region. The spectrometer may also include a light source and the light detectors formed on a single substrate. The light source may be a light emitting diode and the light detectors may be a photodiode comprising multiple channels, where both devices are formed on a silicon substrate. The light detector can include multiple channels to detect light emission at multiple wavelengths.
- Still referring to FIG. 2,
probe array 11 may be integrally molded onto the surface of thespectrometer module 43 creating a somewhat simplified one-piece unit which may provide processing advantages in high speed production environments where parts counts are intentionally kept low to minimize stock and therefore reduce cost of fabrication and assembly. Injection molding or casting of the components is effective to produce miniature components that correspond in size to conventional silicon-based integrated circuit scale. Therefore it should be appreciated that the RPAM may be small, e.g., about the size of a miniature electronic component such as a surface mount device. Such devices include packaging, leads, and other components, and may be obtainable in size ranges of less than 1 mm in length. Such devices may typically be configured in the range from about 0.5 mm to about 3 mm to produce small, useful devices for in vivo use. TheRPAM 41 may also have printable surfaces according to the construction of alternative probe array configurations as described in FIG. 1A and FIG. 1B, if desired. Referring once again to FIG. 2, the internal components of the RPAM consist of a substrate material 49 such as silicon upon which a light-emittingdiode light source 51 is mounted withpower lead 53 attached to one ofterminals 55. Various colors and types of diode light sources may be used, including those now available that emit light in the infrared, the red, the yellow, the green, the blue, and the blue-violet regions. A working range of RPAM excitation wavelengths is from about 1100 nanometers to about 250 nanometers and may comprise monochromatic, bichromatic or broadband emissions. Theexit aperture 57 is positioned to illuminatemovable mirror 59 which is bonded topiezoelectric stack actuator 61. Empowerment of thestack actuator 61 is effective to direct light emission fromdiode light source 51 to one ormore chambers 13. Light emission from theprobe materials 21 is picked up by one or more light detectors 63 throughfilters 65. Signals from the detectors 63 are brought out from the RPAM throughother terminals 55. - Referring now to FIG. 2A, the operation of the RPAM is depicted in block diagram form as follows: Light is generated and directed from
light source 51 and directed at one or more ofchambers 13 bymirror 59, which impinges upon at least oneprobe material 21. Fluorescence or other secondary light generated by the action of the light energy upon the probe material causes a second emission that may be detected by one or more light detectors 63 after passing through abandpass filter 65. The signal may be amplified and/or conditioned by one or more amplifier stages 64.Filters 65 allow the system to discriminate between various secondary light emission wavelengths, and signals from said light detectors 63 may be synchronized with the operation oflight source 51 so that at any given time there is a known relationship between the particular probe that is illuminated and its response as detected by the light detectors. The timing and relationship of the light generating and light detecting event and the spatial position of themirror 59, are controlled by CPU 71 and sent to the components via control lines 73. - The data obtained may be stored or presented in a display device or other therapeutic device which can be a graphical display, a television monitor, printout or drug delivery pump, interventional device, motor or actuator, etc. Accordingly, this apparatus may effectively scan or read a plurality of probe materials in a repeatable, fast and controllable manner, and the information read may be stored, displayed, or used to initiate another action such as a therapeutic application of a drug, or control of a motor. The bandpass filter system of detecting one or more light wavelengths for this purpose is basic and that more complex schemes could be employed by those of ordinary skill in the art. Such schemes may include, without limitation; light wavelength detection systems comprising gratings, graduated filters, heterodyne detection, acousto-optic tunable filtering, and other light detectors that effectively provide and amplitude and frequency responsive signal. A diffraction grating (not shown), for instance, may be attached to
movable mirror 59 to provide spatial and chromatic control simultaneously. - Referring now to FIG. 3, the cross sectional view of an interventional device incorporating the spectrometer and probe still referred to here as RPAM41; there is a body-
insertable appliance 81 such as a catheter which may have a distal end and a proximal end and may consist of a plastic, rubber or metal material that is generally elongated in shape, has a small cross-section allowing it to pass easily through the body, and has one or more lumens or conduits which may extend through the length of the device. Shown in FIG. 3 is a device having three lumens although a greater or lesser number of lumens may be used depending upon the application for which the device is intended. The main lumen 83 is relatively large and is used to deliver a drug, a reagent, or a device to or beyond the distal tip 89. Suction lumen 85 is useful for drawing biological fluids, tissue or other materials into proximity with theRPAM 41, where the material can be analyzed.Signal wires 74 may extend to an external controller (not shown) or to a CPU, pump, motor or other controller as shown in FIG. 2A, 75. - Returning once again to FIG. 3, infusion lumen87 may provide additional fluids, regents, drugs, wires or appliances that may be useful to the procedure. For example, the practitioner will appreciate that additional reagents can be introduced to facilitate analysis. Such additional reagents can include: denaturants, such as guanidinium thiosulfate; buffers, such as Tris-Cl; detergents, such as SDS; chelators, such as EDTA; enzymes, such as proteinases and/or DNAases; and other reagents known to those of ordinary skill in the art which may be appropriate to the particular analysis to be carried out using the apparatus of the present invention.
- Referring now to FIG. 4, a cross sectional view of an interventional device such as a
body insertable appliance 81 fitted with a lysingcore 101, is shown. The lysingcore 101 utilizes mechanical motion to disrupt cells in order to make the cell contents available for analysis by the RPAM (not shown). The use of a lysing device in conjunction with the RPAM system eliminates the need for potentially toxic reagents that are commonly used to open cells in vitro. The lysing head 105 consists here of a more or less hemispherical component that may be comprised of a metal or plastic, which is mounted at the distal end of adriveshaft 103. Such driveshafts are well known for their ability to deliver torque and rotary motion from aproximal motor 107 or by hand control. As taught in this invention,motor 107 is one of a class of components shown in FIG. 2A as 75 which may be controlled by system CPU 71, also shown in FIG. 2A. Numerous other lysing devices are known that may abrade, disrupt, dissolve, pressurize, vacuum, cavitate or otherwise apply mechanical forces to a cell or cells that is effective to disrupt the cell and make its contents available for analysis. It should be pointed out that such damage to cells is usually minimized to avoid permanent damage to the organ, vessel, duct or tissue being tested. The lysing head 105 need not be relatively large and may be made small enough so that it may easily pass through the device from the proximal end so that another device or implant may be inserted, if needed, through the same large lumen 83. Such an implant may be a solid or porous, foraminous or dissolvable seed, implant, stent, gel or the like, which may carry therapeutic agents to a particular site in the body. This system provides the advantage that local conditions can be determined through use of the polydeoxynucleotide readable array (afforded by the construction of the RPAM device as described herein), and therefore, better and more precise application of appropriate medicaments, drugs, therapeutic genetically based substances, etc., is facilitated. Further advantages are provided in that the information is obtained at or near real time, and that information is obtainable from the exact location of a proposed therapeutic intervention. Such a device that may be used to place an implant is shown in FIG. 5, which is a side view of a secondaryinsertable device 111 comprising a rotary, multifilarflexible driveshaft 112 having atherapeutic tip 113 terminating in ananchoring device 115 shown as a screw form capable of being screwed into tissue until separable joint 117 breaks, after which the remaining part ofinsertable device 111 may be withdrawn.Driveshaft 112 may be hollow, to allowtether 119 to remain attached totherapeutic tip 113. Tether material may be constructed of a wire to allow the sending and receiving of an electrical signal, or may simply be used as a retrieval device to retrieve any portion of the therapeutic tip that may remain after the need for it is over. - Numerous carrying devices may be used to deliver the RPAM. FIG. 6 is a cross sectional view of a
hollow needle 121 carrying the RPAMinsertable appliance 81. The advantage of a needle is that it allows the introduction of the RPAM into portions of the body where there is no natural passageway. This method allows the user to position the distal tip of the lysing head 105 in various positions with respect to thesharp needle tip 106. The needle may be of stainless steel and may be inserted into body tissue such as muscle, breast, prostate, or cardiac tissue. The needle may be left in place, and the RPAM withdrawn temporarily to allow another appliance (not shown) to be introduced. Other carrying devices may include guidewires, balloon catheters, ultrasound catheters with both imaging or non-imaging, and rotatable or array configurations, introducer sheaths, balloon angioplasty catheters for use in the blood vessels of the heart, the extremities, and the vascular system, atherectomy catheters, and many other types of interventional devices, as well as intraoperative devices. The device of the invention may be used anywhere there is the need for fast, precise localized detection and analysis of nucleotides, proteins or the like, either for diagnostic purposes, or to guide therapy which itself may be made more localized, and therefore site-specific. Such uses are economical and have less impact on surrounding tissue that is free of disease. The invention allows use of any agent that may change color as a result of the application of a local chemical to be read and includes without limitation such agents as litmus, photodynamic therapeutic agents such as photofrin, fluorescent agents or dyes, staining dyes, luciferin, etc. The present invention permits analysis in a real time fashion without the need to remove and transport tissue specimens for later analysis.
Claims (43)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/881,283 US7302289B2 (en) | 1998-01-20 | 2001-06-14 | Readable probe array for in-vivo use |
US11/621,415 US8140148B2 (en) | 1998-01-20 | 2007-01-09 | Readable probe array for in vivo use |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7190698P | 1998-01-20 | 1998-01-20 | |
US09/233,409 US6289229B1 (en) | 1998-01-20 | 1999-01-19 | Readable probe array for in vivo use |
US09/881,283 US7302289B2 (en) | 1998-01-20 | 2001-06-14 | Readable probe array for in-vivo use |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/233,409 Continuation US6289229B1 (en) | 1998-01-20 | 1999-01-19 | Readable probe array for in vivo use |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/621,415 Continuation US8140148B2 (en) | 1998-01-20 | 2007-01-09 | Readable probe array for in vivo use |
Publications (2)
Publication Number | Publication Date |
---|---|
US20010029328A1 true US20010029328A1 (en) | 2001-10-11 |
US7302289B2 US7302289B2 (en) | 2007-11-27 |
Family
ID=26752804
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/233,409 Expired - Lifetime US6289229B1 (en) | 1998-01-20 | 1999-01-19 | Readable probe array for in vivo use |
US09/881,283 Expired - Fee Related US7302289B2 (en) | 1998-01-20 | 2001-06-14 | Readable probe array for in-vivo use |
US11/621,415 Expired - Fee Related US8140148B2 (en) | 1998-01-20 | 2007-01-09 | Readable probe array for in vivo use |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/233,409 Expired - Lifetime US6289229B1 (en) | 1998-01-20 | 1999-01-19 | Readable probe array for in vivo use |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/621,415 Expired - Fee Related US8140148B2 (en) | 1998-01-20 | 2007-01-09 | Readable probe array for in vivo use |
Country Status (1)
Country | Link |
---|---|
US (3) | US6289229B1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070088195A1 (en) * | 2005-10-18 | 2007-04-19 | Boston Scientific Scimed, Inc. | Method of using an imaging catheter to conduct photodynamic procedures |
US10517569B2 (en) | 2012-05-09 | 2019-12-31 | The Regents Of The University Of Michigan | Linear magnetic drive transducer for ultrasound imaging |
Families Citing this family (103)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7637948B2 (en) | 1997-10-10 | 2009-12-29 | Senorx, Inc. | Tissue marking implant |
US8668737B2 (en) | 1997-10-10 | 2014-03-11 | Senorx, Inc. | Tissue marking implant |
US6289229B1 (en) | 1998-01-20 | 2001-09-11 | Scimed Life Systems, Inc. | Readable probe array for in vivo use |
PT1108207E (en) | 1998-08-26 | 2008-08-06 | Sensors For Med & Science Inc | Optical-based sensing devices |
US20030028501A1 (en) * | 1998-09-17 | 2003-02-06 | David J. Balaban | Computer based method for providing a laboratory information management system |
US6862470B2 (en) | 1999-02-02 | 2005-03-01 | Senorx, Inc. | Cavity-filling biopsy site markers |
US20090216118A1 (en) | 2007-07-26 | 2009-08-27 | Senorx, Inc. | Polysaccharide markers |
US9820824B2 (en) | 1999-02-02 | 2017-11-21 | Senorx, Inc. | Deployment of polysaccharide markers for treating a site within a patent |
US8498693B2 (en) | 1999-02-02 | 2013-07-30 | Senorx, Inc. | Intracorporeal marker and marker delivery device |
US8361082B2 (en) | 1999-02-02 | 2013-01-29 | Senorx, Inc. | Marker delivery device with releasable plug |
US7651505B2 (en) | 2002-06-17 | 2010-01-26 | Senorx, Inc. | Plugged tip delivery for marker placement |
US7983734B2 (en) | 2003-05-23 | 2011-07-19 | Senorx, Inc. | Fibrous marker and intracorporeal delivery thereof |
US6725083B1 (en) | 1999-02-02 | 2004-04-20 | Senorx, Inc. | Tissue site markers for in VIVO imaging |
JP2000262460A (en) * | 1999-03-18 | 2000-09-26 | Inst Of Physical & Chemical Res | Method for detecting specified location, method for biological measurement, device for detecting specified location of biological sample, and optical fiber holding device |
US6575991B1 (en) * | 1999-06-17 | 2003-06-10 | Inrad, Inc. | Apparatus for the percutaneous marking of a lesion |
US6728565B2 (en) * | 2000-02-25 | 2004-04-27 | Scimed Life Systems, Inc. | Diagnostic catheter using a vacuum for tissue positioning |
US7553280B2 (en) * | 2000-06-29 | 2009-06-30 | Sensors For Medicine And Science, Inc. | Implanted sensor processing system and method |
WO2002039112A2 (en) * | 2000-11-09 | 2002-05-16 | Sicel Technologies, Inc. | In vivo detection of biomolecule concentrations using fluorescent tags |
CA2775170C (en) | 2000-11-20 | 2017-09-05 | Senorx, Inc. | An intracorporeal marker delivery system for marking a tissue site |
BR0209357A (en) * | 2001-05-04 | 2004-06-08 | Sensors For Med & Science Inc | Electro-reading device with reference channel |
US20030054396A1 (en) * | 2001-09-07 | 2003-03-20 | Weiner Michael P. | Enzymatic light amplification |
US8423110B2 (en) * | 2002-01-09 | 2013-04-16 | Boston Scientific Scimed, Inc. | Imaging device and related methods |
US8131332B2 (en) * | 2002-04-04 | 2012-03-06 | Veralight, Inc. | Determination of a measure of a glycation end-product or disease state using tissue fluorescence of various sites |
US6925322B2 (en) * | 2002-07-25 | 2005-08-02 | Biophan Technologies, Inc. | Optical MRI catheter system |
US20060036158A1 (en) | 2003-11-17 | 2006-02-16 | Inrad, Inc. | Self-contained, self-piercing, side-expelling marking apparatus |
US20050154277A1 (en) * | 2002-12-31 | 2005-07-14 | Jing Tang | Apparatus and methods of using built-in micro-spectroscopy micro-biosensors and specimen collection system for a wireless capsule in a biological body in vivo |
KR20060004942A (en) * | 2003-04-15 | 2006-01-16 | 센서즈 포 메드슨 앤드 사이언스 인코포레이티드 | Printed circuit device with integrated antenna and implantable sensor processing system with integrated printed circuit board antenna |
US7877133B2 (en) | 2003-05-23 | 2011-01-25 | Senorx, Inc. | Marker or filler forming fluid |
US7321791B2 (en) * | 2003-09-23 | 2008-01-22 | Cambridge Research And Instrumentation, Inc. | Spectral imaging of deep tissue |
US8634607B2 (en) | 2003-09-23 | 2014-01-21 | Cambridge Research & Instrumentation, Inc. | Spectral imaging of biological samples |
US20050273002A1 (en) | 2004-06-04 | 2005-12-08 | Goosen Ryan L | Multi-mode imaging marker |
US7496392B2 (en) * | 2003-11-26 | 2009-02-24 | Becton, Dickinson And Company | Fiber optic device for sensing analytes |
US7787923B2 (en) * | 2003-11-26 | 2010-08-31 | Becton, Dickinson And Company | Fiber optic device for sensing analytes and method of making same |
EP1720448A1 (en) * | 2004-02-24 | 2006-11-15 | Wisconsin Alumni Research Foundation | Side-firing probe for performing optical spectroscopy during core needle biopsy |
GB0419325D0 (en) * | 2004-09-01 | 2004-09-29 | Perkinelmer Ltd | A method of analysing a sample including fluorescent labels and apparatus therefor |
KR20070083854A (en) * | 2004-09-29 | 2007-08-24 | 머티리얼스 리서치 서비시즈 | Ir spectrographic apparatus and method for diagnosis of disease |
US8419656B2 (en) | 2004-11-22 | 2013-04-16 | Bard Peripheral Vascular, Inc. | Post decompression marker introducer system |
ATE527619T1 (en) | 2005-01-27 | 2011-10-15 | Cambridge Res & Instrumentation Inc | CLASSIFICATION OF IMAGE PROPERTIES |
US7308292B2 (en) | 2005-04-15 | 2007-12-11 | Sensors For Medicine And Science, Inc. | Optical-based sensing devices |
US10357328B2 (en) | 2005-04-20 | 2019-07-23 | Bard Peripheral Vascular, Inc. and Bard Shannon Limited | Marking device with retractable cannula |
US7883542B2 (en) * | 2005-06-03 | 2011-02-08 | Zipnick Richard I | Minimally invasive apparatus to manipulate and revitalize spinal column disc |
WO2006133392A1 (en) * | 2005-06-08 | 2006-12-14 | Vanderbilt University | Sampling of blood analytes |
FR2887625B1 (en) * | 2005-06-23 | 2007-12-28 | Univ Nantes Etablissement Publ | SENSOR FOR A SPECTROMETER, INTEGRATING ITS OWN LIGHT EXCITATION SOURCE AND CORRESPONDING SPECTROMETER |
FR2887626B1 (en) * | 2005-06-23 | 2008-02-15 | Univ Nantes Etablissement Publ | SPECTROMETER SENSOR, THE OPTICAL MEANS OF WHICH ARE MOBILE, AND CORRESPONDING SPECTROMETER |
US20090093403A1 (en) | 2007-03-01 | 2009-04-09 | Feng Zhang | Systems, methods and compositions for optical stimulation of target cells |
WO2007024391A2 (en) | 2005-07-22 | 2007-03-01 | The Board Of Trustees Of The Leland Stanford Junior University | Light-activated cation channel and uses thereof |
US8926959B2 (en) | 2005-07-22 | 2015-01-06 | The Board Of Trustees Of The Leland Stanford Junior University | System for optical stimulation of target cells |
US9274099B2 (en) | 2005-07-22 | 2016-03-01 | The Board Of Trustees Of The Leland Stanford Junior University | Screening test drugs to identify their effects on cell membrane voltage-gated ion channel |
US7660616B1 (en) * | 2005-09-20 | 2010-02-09 | Pacesetter, Inc. | Implantable multi-wavelength oximeter sensor |
US7630078B1 (en) | 2005-09-20 | 2009-12-08 | Pacesetter, Inc. | Calibrating implantable optical sensors |
US7840246B1 (en) | 2005-09-20 | 2010-11-23 | Pacesetter, Inc. | Implantable self-calibrating optical sensors |
US8052658B2 (en) | 2005-10-07 | 2011-11-08 | Bard Peripheral Vascular, Inc. | Drug-eluting tissue marker |
US9168383B2 (en) | 2005-10-14 | 2015-10-27 | Pacesetter, Inc. | Leadless cardiac pacemaker with conducted communication |
EP2471448A1 (en) | 2005-10-14 | 2012-07-04 | Nanostim, Inc. | Leadless cardiac pacemaker and system |
US20070287991A1 (en) * | 2006-06-08 | 2007-12-13 | Mckay William F | Devices and methods for detection of markers of axial pain with or without radiculopathy |
US8333697B2 (en) * | 2006-06-08 | 2012-12-18 | Warsaw Orthopedic, Inc. | Diagnostic kits and methods for diagnosis of axial pain with or without radiculopathy |
US20080033412A1 (en) * | 2006-08-01 | 2008-02-07 | Harry Thomas Whelan | System and method for convergent light therapy having controllable dosimetry |
EP2079385B1 (en) | 2006-10-23 | 2013-11-20 | C.R.Bard, Inc. | Breast marker |
WO2008073965A2 (en) | 2006-12-12 | 2008-06-19 | C.R. Bard Inc. | Multiple imaging mode tissue marker |
ES2432572T3 (en) | 2006-12-18 | 2013-12-04 | C.R. Bard, Inc. | Biopsy marker with imaging properties generated in situ |
WO2008086470A1 (en) | 2007-01-10 | 2008-07-17 | The Board Of Trustees Of The Leland Stanford Junior University | System for optical stimulation of target cells |
WO2009036396A1 (en) * | 2007-09-14 | 2009-03-19 | Light Sciences Oncology, Inc. | Systems, devices, and methods for photoactive assisted resection |
SE531527C2 (en) * | 2007-10-01 | 2009-05-12 | Bioresonator Ab | Method and apparatus for unaffected material examination |
US10434327B2 (en) | 2007-10-31 | 2019-10-08 | The Board Of Trustees Of The Leland Stanford Junior University | Implantable optical stimulators |
FI120336B (en) * | 2007-12-21 | 2009-09-30 | Medisize Oy | Pipette frame, pipette tip and procedure |
US8311610B2 (en) | 2008-01-31 | 2012-11-13 | C. R. Bard, Inc. | Biopsy tissue marker |
KR20110005280A (en) | 2008-04-23 | 2011-01-17 | 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 | Systems, methods and compositions for optical stimulation of target cells |
JP5887136B2 (en) | 2008-06-17 | 2016-03-16 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | Apparatus and method for controlling cell development |
MY156389A (en) * | 2008-06-17 | 2016-02-15 | Univ Leland Stanford Junior | Methods, systems and devices for optical stimulation of target cells using an optical transmission element |
WO2010006049A1 (en) | 2008-07-08 | 2010-01-14 | The Board Of Trustees Of The Leland Stanford Junior University | Materials and approaches for optical stimulation of the peripheral nervous system |
US9327061B2 (en) | 2008-09-23 | 2016-05-03 | Senorx, Inc. | Porous bioabsorbable implant |
ES2560515T3 (en) | 2008-12-30 | 2016-02-19 | C.R. Bard, Inc. | Marker administration device for tissue marker placement |
US8527068B2 (en) | 2009-02-02 | 2013-09-03 | Nanostim, Inc. | Leadless cardiac pacemaker with secondary fixation capability |
CN103249452A (en) | 2010-10-12 | 2013-08-14 | 内诺斯蒂姆股份有限公司 | Temperature sensor for a leadless cardiac pacemaker |
US9060692B2 (en) | 2010-10-12 | 2015-06-23 | Pacesetter, Inc. | Temperature sensor for a leadless cardiac pacemaker |
US9020611B2 (en) | 2010-10-13 | 2015-04-28 | Pacesetter, Inc. | Leadless cardiac pacemaker with anti-unscrewing feature |
CA2816990A1 (en) | 2010-11-05 | 2012-05-10 | The Board Of Trustees Of The Leland Stanford Junior University | Stabilized step function opsin proteins and methods of using the same |
WO2012061684A1 (en) | 2010-11-05 | 2012-05-10 | The Board Of Trustees Of The Leland Stanford Junior University | Upconversion of light for use in optogenetic methods |
ES2716819T3 (en) | 2010-11-05 | 2019-06-17 | Univ Leland Stanford Junior | Chimeric opposites activated by light and methods of using them |
US8696722B2 (en) | 2010-11-22 | 2014-04-15 | The Board Of Trustees Of The Leland Stanford Junior University | Optogenetic magnetic resonance imaging |
EP2651494B1 (en) | 2010-12-13 | 2017-02-15 | Pacesetter, Inc. | Delivery catheter |
EP2651502B1 (en) | 2010-12-13 | 2016-11-09 | Pacesetter, Inc. | Pacemaker retrieval systems |
JP2014501584A (en) | 2010-12-20 | 2014-01-23 | ナノスティム・インコーポレイテッド | Leadless space maker with radial fixing mechanism |
WO2013043344A1 (en) | 2011-09-21 | 2013-03-28 | Boston Scientific Scimed, Inc. | Systems and methods for preventing laser fiber misfiring within endoscopic access devices |
WO2013067496A2 (en) | 2011-11-04 | 2013-05-10 | Nanostim, Inc. | Leadless cardiac pacemaker with integral battery and redundant welds |
US9365628B2 (en) | 2011-12-16 | 2016-06-14 | The Board Of Trustees Of The Leland Stanford Junior University | Opsin polypeptides and methods of use thereof |
WO2013126521A1 (en) | 2012-02-21 | 2013-08-29 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions and methods for treating neurogenic disorders of the pelvic floor |
US8808373B2 (en) | 2012-06-13 | 2014-08-19 | Elwha Llc | Breast implant with regionalized analyte sensors responsive to external power source |
US8790400B2 (en) | 2012-06-13 | 2014-07-29 | Elwha Llc | Breast implant with covering and analyte sensors responsive to external power source |
US9211185B2 (en) | 2012-06-13 | 2015-12-15 | Elwha Llc | Breast implant with analyte sensors and internal power source |
US8795359B2 (en) | 2012-06-13 | 2014-08-05 | Elwha Llc | Breast implant with regionalized analyte sensors and internal power source |
US9144488B2 (en) | 2012-06-13 | 2015-09-29 | Elwha Llc | Breast implant with analyte sensors responsive to external power source |
US9144489B2 (en) | 2012-06-13 | 2015-09-29 | Elwha Llc | Breast implant with covering, analyte sensors and internal power source |
EP2885627B1 (en) | 2012-07-29 | 2019-05-15 | Hewlett-Packard Development Company, L.P. | Implantable nanosensor |
US9802054B2 (en) | 2012-08-01 | 2017-10-31 | Pacesetter, Inc. | Biostimulator circuit with flying cell |
EP2968997B1 (en) | 2013-03-15 | 2019-06-26 | The Board of Trustees of the Leland Stanford Junior University | Optogenetic control of behavioral state |
EP2991491B1 (en) | 2013-04-29 | 2019-12-25 | The Board of Trustees of the Leland Stanford Junior University | Devices, systems and methods for optogenetic modulation of action potentials in target cells |
CN105829538A (en) | 2013-08-14 | 2016-08-03 | 小利兰·斯坦福大学托管委员会 | Silicone-modified polyester coating |
USD716451S1 (en) | 2013-09-24 | 2014-10-28 | C. R. Bard, Inc. | Tissue marker for intracorporeal site identification |
USD715942S1 (en) | 2013-09-24 | 2014-10-21 | C. R. Bard, Inc. | Tissue marker for intracorporeal site identification |
USD716450S1 (en) | 2013-09-24 | 2014-10-28 | C. R. Bard, Inc. | Tissue marker for intracorporeal site identification |
USD715442S1 (en) | 2013-09-24 | 2014-10-14 | C. R. Bard, Inc. | Tissue marker for intracorporeal site identification |
WO2016209654A1 (en) | 2015-06-22 | 2016-12-29 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and devices for imaging and/or optogenetic control of light-responsive neurons |
Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4832034A (en) * | 1987-04-09 | 1989-05-23 | Pizziconi Vincent B | Method and apparatus for withdrawing, collecting and biosensing chemical constituents from complex fluids |
US5408996A (en) * | 1993-03-25 | 1995-04-25 | Salb; Jesse | System and method for localization of malignant tissue |
US5412087A (en) * | 1992-04-24 | 1995-05-02 | Affymax Technologies N.V. | Spatially-addressable immobilization of oligonucleotides and other biological polymers on surfaces |
US5716981A (en) * | 1993-07-19 | 1998-02-10 | Angiogenesis Technologies, Inc. | Anti-angiogenic compositions and methods of use |
US5833603A (en) * | 1996-03-13 | 1998-11-10 | Lipomatrix, Inc. | Implantable biosensing transponder |
US5984861A (en) * | 1997-09-29 | 1999-11-16 | Boston Scientific Corporation | Endofluorescence imaging module for an endoscope |
US6119031A (en) * | 1996-11-21 | 2000-09-12 | Boston Scientific Corporation | Miniature spectrometer |
US6122536A (en) * | 1995-07-06 | 2000-09-19 | Animas Corporation | Implantable sensor and system for measurement and control of blood constituent levels |
US6185443B1 (en) * | 1997-09-29 | 2001-02-06 | Boston Scientific Corporation | Visible display for an interventional device |
US6201989B1 (en) * | 1997-03-13 | 2001-03-13 | Biomax Technologies Inc. | Methods and apparatus for detecting the rejection of transplanted tissue |
US6238348B1 (en) * | 1997-07-22 | 2001-05-29 | Scimed Life Systems, Inc. | Miniature spectrometer system and method |
US6322495B1 (en) * | 1998-01-15 | 2001-11-27 | Scimed Life Systems, Inc. | Method for placing a feeding tube inside a gastro-intestinal tract |
US6324418B1 (en) * | 1997-09-29 | 2001-11-27 | Boston Scientific Corporation | Portable tissue spectroscopy apparatus and method |
Family Cites Families (270)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2583937A (en) | 1952-01-29 | Surgical exploring and operating | ||
US2002559A (en) | 1932-04-13 | 1935-05-28 | Wappler Frederick Charles | Means for surgical resection |
DE888727C (en) | 1941-04-22 | 1953-09-03 | Quarzlampen Gmbh | Body cavity irradiation lamp |
US2582937A (en) | 1948-11-04 | 1952-01-15 | Ohio Brass Co | Rail bond |
US3176114A (en) | 1962-07-16 | 1965-03-30 | Richard F Kneisley | Device for removing nasal hair |
GB1485908A (en) | 1974-05-21 | 1977-09-14 | Nath G | Apparatus for applying light radiation |
US4215275A (en) | 1977-12-07 | 1980-07-29 | Luxtron Corporation | Optical temperature measurement technique utilizing phosphors |
US4274706A (en) | 1979-08-30 | 1981-06-23 | Hughes Aircraft Company | Wavelength multiplexer/demultiplexer for optical circuits |
US4774191A (en) | 1979-09-07 | 1988-09-27 | Syntex (U.S.A.) Inc. | Fluorescent conjugates bound to a support |
US4289966A (en) | 1980-04-10 | 1981-09-15 | The United States Of America As Represented By The Secretary Of The Army | Radiation energy detector and analyzer |
DE3023130A1 (en) | 1980-06-20 | 1982-01-21 | Hasso von 4000 Düsseldorf Blücher | Mouth and nose steriliser - uses high intensity light flash of millisecond duration |
US4340307A (en) | 1980-07-07 | 1982-07-20 | Beckman Instruments, Inc. | Bichromatic spectrophotometer with wavelength reversal |
US4803992A (en) | 1980-10-28 | 1989-02-14 | Lemelson Jerome H | Electro-optical instruments and methods for producing same |
US4578061A (en) | 1980-10-28 | 1986-03-25 | Lemelson Jerome H | Injection catheter and method |
US4566057A (en) | 1981-01-02 | 1986-01-21 | Prescolite, Inc. | Recessed lighting housing |
JPS57175345A (en) | 1981-04-22 | 1982-10-28 | Sumitomo Electric Industries | Sensor for live body organ spectrum analyser |
US4472728A (en) | 1982-02-19 | 1984-09-18 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Imaging X-ray spectrometer |
US5928222A (en) * | 1982-08-06 | 1999-07-27 | Kleinerman; Marcos Y. | Fiber optic sensing techniques in laser medicine |
JPS5940830A (en) | 1982-08-31 | 1984-03-06 | 浜松ホトニクス株式会社 | Apparatus for diagnosis of cancer using laser beam pulse |
US4541272A (en) | 1983-05-13 | 1985-09-17 | Roland Bause | Electronically controlled fuel injection system |
US4987065A (en) | 1983-07-05 | 1991-01-22 | Enzo Biochem, Inc. | In vivo labelling of polynucleotide sequences |
US4938218A (en) | 1983-08-30 | 1990-07-03 | Nellcor Incorporated | Perinatal pulse oximetry sensor |
JPS6077731A (en) | 1983-10-03 | 1985-05-02 | オリンパス光学工業株式会社 | Endoscope apparatus using solid-image pick-up element |
US4570638A (en) | 1983-10-14 | 1986-02-18 | Somanetics Corporation | Method and apparatus for spectral transmissibility examination and analysis |
US4743534A (en) | 1983-11-30 | 1988-05-10 | Minnesota Mining And Manufacturing Company | Preformed silver halides for photothermographic system |
US5597692A (en) | 1984-04-05 | 1997-01-28 | Howard Florey Institute Of Experimental Physiology And Medicine | Hybridization histochemistry method for determining the presence and location in animal or plant tissue of RNA |
US4670380A (en) | 1984-05-23 | 1987-06-02 | Molecular Diagnostics, Inc. | Assays utilizing labeled nucleic acid probes |
US5503979A (en) | 1984-05-25 | 1996-04-02 | The Trustees Of Columbia University In The City Of New York | Method of using replicatable hybridzable recombinant RNA probes |
US4652517A (en) | 1984-06-11 | 1987-03-24 | Diagnostic Research Limited Partnership | Methods for the in vitro detection and identification of unknown pathogens or genetic entities |
US4672972A (en) | 1984-08-13 | 1987-06-16 | Berke Howard R | Solid state NMR probe |
US5034010A (en) | 1985-03-22 | 1991-07-23 | Massachusetts Institute Of Technology | Optical shield for a laser catheter |
US5125404A (en) | 1985-03-22 | 1992-06-30 | Massachusetts Institute Of Technology | Apparatus and method for obtaining spectrally resolved spatial images of tissue |
US5106387A (en) | 1985-03-22 | 1992-04-21 | Massachusetts Institute Of Technology | Method for spectroscopic diagnosis of tissue |
US4718417A (en) | 1985-03-22 | 1988-01-12 | Massachusetts Institute Of Technology | Visible fluorescence spectral diagnostic for laser angiosurgery |
US5318024A (en) | 1985-03-22 | 1994-06-07 | Massachusetts Institute Of Technology | Laser endoscope for spectroscopic imaging |
US4824776A (en) | 1985-07-25 | 1989-04-25 | Molecular Biosystems, Inc. | Method for increasing the sensitivity of nucleic acid hybridization assays |
US5042494A (en) | 1985-11-13 | 1991-08-27 | Alfano Robert R | Method and apparatus for detecting cancerous tissue using luminescence excitation spectra |
US4930516B1 (en) | 1985-11-13 | 1998-08-04 | Laser Diagnostic Instr Inc | Method for detecting cancerous tissue using visible native luminescence |
US4770992A (en) | 1985-11-27 | 1988-09-13 | Den Engh Gerrit J Van | Detection of specific DNA sequences by flow cytometry |
US4882269A (en) | 1985-12-13 | 1989-11-21 | Princeton University | Amplified hybridization assay |
US4996143A (en) | 1985-12-23 | 1991-02-26 | Syngene, Inc. | Fluorescent stokes shift probes for polynucleotide hybridization |
US4895156A (en) | 1986-07-02 | 1990-01-23 | Schulze John E | Sensor system using fluorometric decay measurements |
US4813790A (en) | 1986-07-28 | 1989-03-21 | Becton, Dickinson And Company | Mouth grips for oral thermometers |
US4872458A (en) | 1986-09-16 | 1989-10-10 | Olympus Optical Co., Ltd. | Thermotherapy apparatus |
SE454781B (en) | 1986-10-17 | 1988-05-30 | Wallac Oy | HYBRIDIZATION PROCEDURE FOR THE DETECTION OF POLYNUCLEOTIDE SEQUENCE |
JPH07108284B2 (en) | 1986-12-26 | 1995-11-22 | オリンパス光学工業株式会社 | Extracorporeal observation device |
US5202231A (en) | 1987-04-01 | 1993-04-13 | Drmanac Radoje T | Method of sequencing of genomes by hybridization of oligonucleotide probes |
US4902896A (en) | 1987-05-08 | 1990-02-20 | Mine Safety Appliances Company | Infrared fluid analyzer |
US4784158A (en) | 1987-08-21 | 1988-11-15 | Okimoto Paul M | Vaginal testing applicator and method |
US4894547A (en) | 1987-09-28 | 1990-01-16 | Yale University | Optical method and apparatus for detecting and measuring aging, photoaging, dermal disease and pigmentation in skin |
US5001556A (en) | 1987-09-30 | 1991-03-19 | Olympus Optical Co., Ltd. | Endoscope apparatus for processing a picture image of an object based on a selected wavelength range |
DE3854781T2 (en) | 1987-10-08 | 1996-05-02 | Pacesetter Ab | Implantable blood oxygen sensor and method of using it |
US4938602A (en) | 1987-10-15 | 1990-07-03 | Electronic Instrumentation And Technology, Inc. | Automated process monitoring |
US5037615A (en) | 1987-10-30 | 1991-08-06 | Cordis Corporation | Tethered pair fluorescence energy transfer indicators, chemical sensors, and method of making such sensors |
US5021888A (en) | 1987-12-18 | 1991-06-04 | Kabushiki Kaisha Toshiba | Miniaturized solid state imaging device |
US4928172A (en) | 1988-01-07 | 1990-05-22 | Olympus Optical Co., Ltd. | Endoscope output signal control device and endoscope apparatus making use of the same |
EP0326395A2 (en) | 1988-01-29 | 1989-08-02 | City Of Hope | Method of detecting and identifying certain viral sequences |
FR2628530B1 (en) | 1988-03-08 | 1994-01-28 | Chemunex Sa | APPARATUS AND METHOD FOR DETECTION AND NUMERATION OF FLUORESCENT PARTICLES, CARRIED BY A SOLID SUPPORT |
US5700637A (en) | 1988-05-03 | 1997-12-23 | Isis Innovation Limited | Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays |
US5242437A (en) | 1988-06-10 | 1993-09-07 | Trimedyne Laser Systems, Inc. | Medical device applying localized high intensity light and heat, particularly for destruction of the endometrium |
US4981138A (en) | 1988-06-30 | 1991-01-01 | Yale University | Endoscopic fiberoptic fluorescence spectrometer |
US5000901A (en) * | 1988-07-25 | 1991-03-19 | Abbott Laboratories | Fiber-optic physiological probes |
US4925268A (en) | 1988-07-25 | 1990-05-15 | Abbott Laboratories | Fiber-optic physiological probes |
US4882623A (en) | 1988-08-11 | 1989-11-21 | Olympus Optical Co., Ltd. | Signal processing apparatus for endoscope capable of changing outline enhancement frequency |
US5036853A (en) | 1988-08-26 | 1991-08-06 | Polartechnics Ltd. | Physiological probe |
US5225326A (en) | 1988-08-31 | 1993-07-06 | Research Development Foundation | One step in situ hybridization assay |
US5099842A (en) | 1988-10-28 | 1992-03-31 | Nellcor Incorporated | Perinatal pulse oximetry probe |
US5402778A (en) | 1993-01-19 | 1995-04-04 | Nim Incorporated | Spectrophotometric examination of tissue of small dimension |
GB8827853D0 (en) | 1988-11-29 | 1988-12-29 | Ares Serono Res & Dev Ltd | Sensor for optical assay |
US5109126A (en) | 1988-12-06 | 1992-04-28 | Worcester Foundation For Experimental Biology | 5'[2'(3')-O-(2,4,6-trinitrophenyl) pyprimidine nucleoside]diphosphate 1-glycosides |
EP0449883B1 (en) | 1988-12-21 | 1996-01-31 | Massachusetts Institute Of Technology | A method for laser induced fluorescence of tissue |
US5553614A (en) | 1988-12-21 | 1996-09-10 | Non-Invasive Technology, Inc. | Examination of biological tissue using frequency domain spectroscopy |
US5187672A (en) | 1989-02-06 | 1993-02-16 | Nim Incorporated | Phase modulation spectroscopic system |
US5555885A (en) | 1988-12-21 | 1996-09-17 | Non-Invasive Technology, Inc. | Examination of breast tissue using time-resolved spectroscopy |
US5386827A (en) | 1993-03-30 | 1995-02-07 | Nim Incorporated | Quantitative and qualitative in vivo tissue examination using time resolved spectroscopy |
CA2007431A1 (en) | 1989-01-10 | 1990-07-10 | Larry W. Mclauglin | Labeling of nucleic acids with fluorescent markers |
GB8902689D0 (en) | 1989-02-07 | 1989-03-30 | Ici Plc | Assay method |
SE8900612D0 (en) | 1989-02-22 | 1989-02-22 | Jonas Johansson | TISSUE CHARACTERIZATION USING A BLOOD-FREE FLUORESCENCE CRITERIA |
WO1990012536A1 (en) | 1989-04-14 | 1990-11-01 | Massachusetts Institute Of Technology | Spectral diagnosis of diseased tissue |
US5421337A (en) | 1989-04-14 | 1995-06-06 | Massachusetts Institute Of Technology | Spectral diagnosis of diseased tissue |
US5201318A (en) | 1989-04-24 | 1993-04-13 | Rava Richard P | Contour mapping of spectral diagnostics |
US5009655A (en) | 1989-05-24 | 1991-04-23 | C. R. Bard, Inc. | Hot tip device with optical diagnostic capability |
US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
US6040138A (en) | 1995-09-15 | 2000-03-21 | Affymetrix, Inc. | Expression monitoring by hybridization to high density oligonucleotide arrays |
US5527681A (en) | 1989-06-07 | 1996-06-18 | Affymax Technologies N.V. | Immobilized molecular synthesis of systematically substituted compounds |
DE69014885T2 (en) | 1989-06-22 | 1995-04-27 | Vestar Inc | CAPSULE PROCEDURE. |
US5024226A (en) | 1989-08-17 | 1991-06-18 | Critikon, Inc. | Epidural oxygen sensor |
US5219727A (en) | 1989-08-21 | 1993-06-15 | Hoffmann-Laroche Inc. | Quantitation of nucleic acids using the polymerase chain reaction |
ES2088432T3 (en) | 1989-09-06 | 1996-08-16 | Pasteur Institut | FRAGMENTS OF NUCLEIC ACIDS DERIVED FROM AN APPROPRIATE MICOBACTERIA GENOME, ITS APPLICATIONS IN THE DIAGNOSIS OF MICOBACTERIA AND PLASMID INFECTIONS CONTAINING SUCH FRAGMENTS. |
US5045056A (en) | 1989-09-15 | 1991-09-03 | Behl Robert S | Method and device for thermal ablation of hollow body organs |
US5188934A (en) | 1989-11-14 | 1993-02-23 | Applied Biosystems, Inc. | 4,7-dichlorofluorescein dyes as molecular probes |
EP0429907B1 (en) | 1989-11-21 | 1994-06-01 | Bayer Ag | Optical biosensor |
JP2852774B2 (en) | 1989-11-22 | 1999-02-03 | 株式会社エス・エル・ティ・ジャパン | Diagnostic device for living tissue and treatment device provided with the diagnostic device |
US5172693A (en) | 1990-01-16 | 1992-12-22 | Doody Michael C | Prenatal non-invasive detection of meconium stained amniotic fluid |
US5131398A (en) | 1990-01-22 | 1992-07-21 | Mediscience Technology Corp. | Method and apparatus for distinguishing cancerous tissue from benign tumor tissue, benign tissue or normal tissue using native fluorescence |
US5453355A (en) | 1990-01-26 | 1995-09-26 | Abbott Laboratories | Oligonucleotides and methods for the detection of Neisseria gonorrhoeae |
US5573907A (en) | 1990-01-26 | 1996-11-12 | Abbott Laboratories | Detecting and amplifying target nucleic acids using exonucleolytic activity |
EP0439968A1 (en) | 1990-02-02 | 1991-08-07 | N.V. Innogenetics S.A. | Hybridization probes for the detection of haemophilus ducreyi strains |
US5541062A (en) | 1990-02-23 | 1996-07-30 | Arch Development Corporation | Methods and compositions for preparing protein processing enzymes |
DE4005743A1 (en) | 1990-02-23 | 1991-08-29 | Wolf Gmbh Richard | Lithotriptor to destroy gallstones intra-or trans-luminally - has shock-wave generator, lead contg. incompressible material, and opt balloon to press generator against gall bladder |
US5424180A (en) | 1990-03-27 | 1995-06-13 | Fuji Photo Film Co., Ltd. | Apparatus for uniform mixing of solutions |
DE69111440T2 (en) * | 1990-04-03 | 1996-03-28 | Genentech Inc | METHODS AND COMPOSITIONS FOR Vaccination Against HIV. |
US5326692B1 (en) | 1992-05-13 | 1996-04-30 | Molecular Probes Inc | Fluorescent microparticles with controllable enhanced stokes shift |
US5082630A (en) | 1990-04-30 | 1992-01-21 | The United States Of America As Represented By The United States Department Of Energy | Fiber optic detector for immuno-testing |
US5143066A (en) * | 1990-05-08 | 1992-09-01 | University Of Pittsburgh | Optical fiber sensors for continuous monitoring of biochemicals and related method |
US5606045A (en) | 1990-05-15 | 1997-02-25 | Diatron Corporation | Nucleic acid probes and methods |
US5166755A (en) | 1990-05-23 | 1992-11-24 | Nahum Gat | Spectrometer apparatus |
US5062428A (en) | 1990-06-04 | 1991-11-05 | Nim Incorporated | Method and device for in vivo diagnosis detecting IR emission by body organ |
US5116759A (en) | 1990-06-27 | 1992-05-26 | Fiberchem Inc. | Reservoir chemical sensors |
US5197470A (en) | 1990-07-16 | 1993-03-30 | Eastman Kodak Company | Near infrared diagnostic method and instrument |
US5166990A (en) | 1990-08-10 | 1992-11-24 | Puritan-Bennett Corporation | Multiple optical fiber event sensor and method of manufacture |
US5168039A (en) | 1990-09-28 | 1992-12-01 | The Board Of Trustees Of The University Of Arkansas | Repetitive DNA sequence specific for mycobacterium tuberculosis to be used for the diagnosis of tuberculosis |
US5053033A (en) | 1990-10-10 | 1991-10-01 | Boston Advanced Technologies, Inc. | Inhibition of restenosis by ultraviolet radiation |
JP3164609B2 (en) | 1990-10-31 | 2001-05-08 | オリンパス光学工業株式会社 | Endoscope device |
YU187991A (en) | 1990-12-11 | 1994-09-09 | Hoechst Aktiengesellschaft | 3- (2) -AMINO-ALI THIOL-MODIFIED, FLUORESCENT-DYED NUCLEOSIDES, NUCLEOTIDS AND OLIGONUCLEOTIDES, PROCESS FOR THEIR OBTAINING AND THEIR USE |
US5193542A (en) | 1991-01-28 | 1993-03-16 | Missanelli John S | Peripartum oximetric monitoring apparatus |
EP0501034A1 (en) | 1991-01-30 | 1992-09-02 | CeramOptec GmbH | Illuminated leading probe device |
US5261410A (en) | 1991-02-07 | 1993-11-16 | Alfano Robert R | Method for determining if a tissue is a malignant tumor tissue, a benign tumor tissue, or a normal or benign tissue using Raman spectroscopy |
EP0525172B1 (en) | 1991-02-13 | 1999-09-01 | Applied Medical Resources, Inc. | Surgical trocar |
WO1992014845A1 (en) | 1991-02-26 | 1992-09-03 | Worcester Foundation For Experimental Biology | Diagnosing cystic fibrosis and other genetic diseases using fluorescence resonance energy transfer (fret) |
US5316000A (en) | 1991-03-05 | 1994-05-31 | Technomed International (Societe Anonyme) | Use of at least one composite piezoelectric transducer in the manufacture of an ultrasonic therapy apparatus for applying therapy, in a body zone, in particular to concretions, to tissue, or to bones, of a living being and method of ultrasonic therapy |
WO1992015883A1 (en) | 1991-03-08 | 1992-09-17 | Amoco Corporation | Improved assays including colored organic compounds |
RU1794088C (en) | 1991-03-18 | 1993-02-07 | Институт Молекулярной Биологии Ан@ Ссср | Method of dna nucleotide sequence determination and a device for its realization |
US5377676A (en) | 1991-04-03 | 1995-01-03 | Cedars-Sinai Medical Center | Method for determining the biodistribution of substances using fluorescence spectroscopy |
US5542928A (en) | 1991-05-17 | 1996-08-06 | Innerdyne, Inc. | Method and device for thermal ablation having improved heat transfer |
DE4119075A1 (en) | 1991-06-10 | 1992-12-17 | Max Planck Gesellschaft | New nucleoside tri:phosphoric acid ester derivs. - used for prepn. of polymerase chain reaction probes, amplification of nucleic acid sequences and as chain terminators for sequences |
US5417210A (en) | 1992-05-27 | 1995-05-23 | International Business Machines Corporation | System and method for augmentation of endoscopic surgery |
US5279309A (en) | 1991-06-13 | 1994-01-18 | International Business Machines Corporation | Signaling device and method for monitoring positions in a surgical operation |
US6287792B1 (en) | 1991-06-17 | 2001-09-11 | The Regents Of The University Of California | Drug delivery of antisense oligonucleotides and peptides to tissues in vivo and to cells using avidin-biotin technology |
US5233621A (en) | 1991-06-27 | 1993-08-03 | Intellectual Property Development Associates Of Connecticut, Inc. | Second harmonic generation and self frequency doubling laser materials comprised of bulk germanosilicate and aluminosilicate glasses |
WO1993003184A1 (en) | 1991-08-09 | 1993-02-18 | Mccann Associates, Inc. | Method for detecting lyme disease and composition |
US5587472A (en) | 1991-08-13 | 1996-12-24 | Bayer Corporation | Coumarin-labeled nucleoside 5'-triphosphates |
US5262645A (en) | 1991-09-03 | 1993-11-16 | General Motors Corporation | Sensor for measuring alcohol content of alcohol gasoline fuel mixtures |
GB9118785D0 (en) | 1991-09-03 | 1991-10-16 | Amersham Int Plc | Labelled primers for nucleic acid probes |
US5506098A (en) | 1991-09-04 | 1996-04-09 | Daikin Industries, Ltd. | In situ hybridization method |
DE4129438A1 (en) | 1991-09-04 | 1993-03-18 | Siemens Ag | MEASURING ARRANGEMENT FOR THE EXAMINATION OF AN OBJECT WITH VISIBLE, NIR OR IR LIGHT |
US5846708A (en) | 1991-11-19 | 1998-12-08 | Massachusetts Institiute Of Technology | Optical and electrical methods and apparatus for molecule detection |
DE69233331T3 (en) | 1991-11-22 | 2007-08-30 | Affymetrix, Inc., Santa Clara | Combinatorial Polymersynthesis Strategies |
US5384261A (en) | 1991-11-22 | 1995-01-24 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis using mechanically directed flow paths |
US5467767A (en) | 1991-11-25 | 1995-11-21 | Alfano; Robert R. | Method for determining if tissue is malignant as opposed to non-malignant using time-resolved fluorescence spectroscopy |
US5348018A (en) | 1991-11-25 | 1994-09-20 | Alfano Robert R | Method for determining if tissue is malignant as opposed to non-malignant using time-resolved fluorescence spectroscopy |
JP3107649B2 (en) | 1991-12-20 | 2000-11-13 | イビデン株式会社 | Fluorescent immunoassay |
US5652099A (en) | 1992-02-12 | 1997-07-29 | Conrad; Michael J. | Probes comprising fluorescent nucleosides and uses thereof |
ATE205542T1 (en) | 1992-03-04 | 2001-09-15 | Univ California | COMPARATIVE GENOME HYBRIDIZATION |
US5213569A (en) | 1992-03-31 | 1993-05-25 | Davis Peter L | Tip for a tissue phacoemulsification device |
US5512757A (en) | 1992-04-06 | 1996-04-30 | Rosemount Analytical, Inc. | Spectrophotometer and optical system therefor |
US5851787A (en) | 1992-04-20 | 1998-12-22 | The General Hospital Corporation | Nucleic acid encoding amyloid precursor-like protein and uses thereof |
US5667667A (en) | 1992-04-24 | 1997-09-16 | Isis Innovation Limited | Electrochemical treatment of surfaces |
DE4213703A1 (en) | 1992-04-25 | 1993-10-28 | Merck Patent Gmbh | Fluorescence-labeled compounds, their production and use |
US5304178A (en) | 1992-05-29 | 1994-04-19 | Acromed Corporation | Sublaminar wire |
US5305748A (en) | 1992-06-05 | 1994-04-26 | Wilk Peter J | Medical diagnostic system and related method |
WO1993025713A1 (en) | 1992-06-17 | 1993-12-23 | Arch Development Corporation | Compositions and methods for detecting gene rearrangements and translocations |
JPH0630799A (en) | 1992-07-10 | 1994-02-08 | Hitachi Ltd | Method for gene detection and device therefor |
US5629147A (en) | 1992-07-17 | 1997-05-13 | Aprogenex, Inc. | Enriching and identifying fetal cells in maternal blood for in situ hybridization |
US5452723A (en) | 1992-07-24 | 1995-09-26 | Massachusetts Institute Of Technology | Calibrated spectrographic imaging |
WO1994002636A1 (en) | 1992-07-28 | 1994-02-03 | Hitachi Chemical Company Ltd. | Gene detection system |
DE69310179T2 (en) * | 1992-07-31 | 1997-07-31 | Behringwerke Ag | METHOD FOR INTRODUCING DEFINED SEQUENCES AT THE 3 'END OF POLYNUCLEOTIDES |
EP0582256A3 (en) | 1992-08-06 | 1997-09-17 | Hitachi Ltd | Polynucleotide detecting method and apparatus |
US5772597A (en) | 1992-09-14 | 1998-06-30 | Sextant Medical Corporation | Surgical tool end effector |
US5206174A (en) | 1992-09-24 | 1993-04-27 | Eg&G Idaho, Inc. | Method of photon spectral analysis |
US5351532A (en) | 1992-10-08 | 1994-10-04 | Paradigm Technologies | Methods and apparatus for making chemical concentration measurements in a sub-surface exploration probe |
US5503980A (en) | 1992-11-06 | 1996-04-02 | Trustees Of Boston University | Positional sequencing by hybridization |
US5795714A (en) | 1992-11-06 | 1998-08-18 | Trustees Of Boston University | Method for replicating an array of nucleic acid probes |
US5556749A (en) | 1992-11-12 | 1996-09-17 | Hitachi Chemical Research Center, Inc. | Oligoprobe designstation: a computerized method for designing optimal DNA probes |
US5383467A (en) | 1992-11-18 | 1995-01-24 | Spectrascience, Inc. | Guidewire catheter and apparatus for diagnostic imaging |
US5445935A (en) | 1992-11-23 | 1995-08-29 | Royer; Catherine A. | Quantitative detection of macromolecules with fluorescent oligonucleotides |
AU5827094A (en) | 1992-12-09 | 1994-07-04 | Graeme Cocks | Electronic video endoscope with non-synchronous exposure |
EP0601889A2 (en) | 1992-12-10 | 1994-06-15 | Maine Medical Center Research Institute | Nucleic acid probes |
US5650278A (en) | 1992-12-22 | 1997-07-22 | Children's Hospital Of Philadelphia | Compositions and diagnostic kits for identifying alveolar rhabdomyosarcoma |
WO1994016104A1 (en) | 1993-01-08 | 1994-07-21 | Ctrc Research Foundation | Color imaging system for use in molecular biology |
DE4302459A1 (en) | 1993-01-29 | 1994-08-04 | Bayer Ag | Nucleotides containing sulfocoumarin and their use in detection methods for nucleic acids |
US5350375A (en) | 1993-03-15 | 1994-09-27 | Yale University | Methods for laser induced fluorescence intensity feedback control during laser angioplasty |
JPH06285106A (en) | 1993-03-30 | 1994-10-11 | Shimadzu Corp | Ultrasonic therapeutic device |
US5413108A (en) | 1993-04-21 | 1995-05-09 | The Research Foundation Of City College Of New York | Method and apparatus for mapping a tissue sample for and distinguishing different regions thereof based on luminescence measurements of cancer-indicative native fluorophor |
US5457027A (en) | 1993-05-05 | 1995-10-10 | Becton, Dickinson And Company | Internal controls for isothermal nucleic acid amplification reactions |
US5421339A (en) | 1993-05-12 | 1995-06-06 | Board Of Regents, The University Of Texas System | Diagnosis of dysplasia using laser induced fluoroescence |
US5545523A (en) | 1993-05-28 | 1996-08-13 | Cornell Research Foundation, Inc. | Methods of detecting bovine herpesvirus 1 (BHV-1) in semen by nucleic acid amplification |
US5695933A (en) | 1993-05-28 | 1997-12-09 | Massachusetts Institute Of Technology | Direct detection of expanded nucleotide repeats in the human genome |
US5858659A (en) | 1995-11-29 | 1999-01-12 | Affymetrix, Inc. | Polymorphism detection |
CA2166201A1 (en) | 1993-06-30 | 1995-01-12 | Barry Colin Crane | Biphasic material |
JPH0723800A (en) | 1993-07-08 | 1995-01-27 | Tanabe Seiyaku Co Ltd | Method for detecting nucleic acid |
CA2167804A1 (en) | 1993-07-20 | 1995-02-02 | Robert H. Singer | In vivo nucleic acid hybridization method |
US5445608A (en) | 1993-08-16 | 1995-08-29 | James C. Chen | Method and apparatus for providing light-activated therapy |
EP0669928A1 (en) | 1993-08-18 | 1995-09-06 | Chromagen, Inc. | Applications of fluorescent n-nucleosides and fluorescent structural analogs of n-nucleosides |
WO1995006062A1 (en) | 1993-08-23 | 1995-03-02 | The University Of Medicine And Dentistry Of New Jersey | Novel proteins isolated from nerve cells, dna sequences encoding same and usages thereof |
US5650399A (en) | 1993-08-23 | 1997-07-22 | The Research Foundation Of State University Of New York | Reactive anthraquinone derivatives and conjugates thereof |
US5456252A (en) | 1993-09-30 | 1995-10-10 | Cedars-Sinai Medical Center | Induced fluorescence spectroscopy blood perfusion and pH monitor and method |
US5472672A (en) | 1993-10-22 | 1995-12-05 | The Board Of Trustees Of The Leland Stanford Junior University | Apparatus and method for polymer synthesis using arrays |
US6156501A (en) | 1993-10-26 | 2000-12-05 | Affymetrix, Inc. | Arrays of modified nucleic acid probes and methods of use |
US6045996A (en) | 1993-10-26 | 2000-04-04 | Affymetrix, Inc. | Hybridization assays on oligonucleotide arrays |
JPH09507121A (en) | 1993-10-26 | 1997-07-22 | アフィマックス テクノロジーズ ナームロゼ ベノートスハップ | Nucleic acid probe array on biological chip |
ZA948393B (en) | 1993-11-01 | 1995-06-26 | Polartechnics Ltd | Method and apparatus for tissue type recognition |
WO1995012349A1 (en) | 1993-11-05 | 1995-05-11 | Aarnoudse, Jan, Gerard | Optical, noninvasive, in-vivo measurement of properties of a constituent of a human or animal body |
US5538848A (en) | 1994-11-16 | 1996-07-23 | Applied Biosystems Division, Perkin-Elmer Corp. | Method for detecting nucleic acid amplification using self-quenching fluorescence probe |
US5417207A (en) | 1993-12-06 | 1995-05-23 | Sensor Devices, Inc. | Apparatus for the invasive use of oximeter probes |
US5681697A (en) | 1993-12-08 | 1997-10-28 | Chiron Corporation | Solution phase nucleic acid sandwich assays having reduced background noise and kits therefor |
US5417688A (en) | 1993-12-22 | 1995-05-23 | Elstrom; John A. | Optical distal targeting system for an intramedullary nail |
US5405369A (en) | 1994-01-25 | 1995-04-11 | Medical College Of Ohio | Photochemical ablation of gastro-intestinal tissue for augmentation of an organ |
US5398844A (en) | 1994-01-31 | 1995-03-21 | Boston Scientific Corporation | Multiple ligating band dispenser |
US5543026A (en) | 1994-02-07 | 1996-08-06 | The Perkin-Elmer Corporation | Real-time scanning fluorescence electrophoresis apparatus for the analysis of polynucleotide fragments |
WO1995023245A1 (en) | 1994-02-25 | 1995-08-31 | Labintelligence, Inc. | Real time in-gel assay |
US5408998A (en) | 1994-03-10 | 1995-04-25 | Ethicon Endo-Surgery | Video based tissue oximetry |
AU2187295A (en) | 1994-03-18 | 1995-10-09 | General Hospital Corporation, The | Cleaved amplified rflp detection methods |
US5590660A (en) | 1994-03-28 | 1997-01-07 | Xillix Technologies Corp. | Apparatus and method for imaging diseased tissue using integrated autofluorescence |
US5552278A (en) | 1994-04-04 | 1996-09-03 | Spectragen, Inc. | DNA sequencing by stepwise ligation and cleavage |
JP3490760B2 (en) | 1994-04-04 | 2004-01-26 | 昭 藤嶋 | Tumor treatment device |
US5610012A (en) | 1994-04-08 | 1997-03-11 | Wisconsin Alumni Research Foundation | DNA probes specific for virulent listeria monocytogenes |
US6689561B1 (en) | 1994-04-14 | 2004-02-10 | The Regents Of The University Of California | Tumor suppressor gene and methods for detection of cancer, monitoring of tumor progression and cancer treatment |
US5547861A (en) | 1994-04-18 | 1996-08-20 | Becton, Dickinson And Company | Detection of nucleic acid amplification |
US5461229A (en) | 1994-06-06 | 1995-10-24 | Unisys Corporation | On-the-go optical spectroscopy soil analyzer |
IL110595A0 (en) | 1994-08-09 | 1994-11-11 | Applitic Ltd | A random access multispectral video and illumination system |
CA2198489A1 (en) | 1994-08-26 | 1996-03-07 | Igen International, Inc. | Biosensor for and method of electrogenerated chemiluminescent detection of nucleic acid adsorbed to a solid surface |
US5491063A (en) | 1994-09-01 | 1996-02-13 | Hoffmann-La Roche Inc. | Methods for in-solution quenching of fluorescently labeled oligonucleotide probes |
JP3675482B2 (en) | 1994-09-09 | 2005-07-27 | カーディオフォーカス・インコーポレイテッド | Phototherapy equipment |
US5517997A (en) | 1994-09-15 | 1996-05-21 | Gabriel Medical, Inc. | Transillumination of body members for protection during body invasive procedures |
US5599668A (en) | 1994-09-22 | 1997-02-04 | Abbott Laboratories | Light scattering optical waveguide method for detecting specific binding events |
US5626139A (en) | 1994-09-23 | 1997-05-06 | Artech Industries, Inc. | Tympanic thermometer |
US5579773A (en) | 1994-09-30 | 1996-12-03 | Martin Marietta Energy Systems, Inc. | Laser-induced differential normalized fluorescence method for cancer diagnosis |
US5545897A (en) | 1994-10-04 | 1996-08-13 | Santa Barbara Research Center | Optically-based chemical detection system |
US5514551A (en) | 1994-10-14 | 1996-05-07 | Gen-Probe Incorporated | Compositions for the detection of Chlamydia trachomatis |
US6974666B1 (en) | 1994-10-21 | 2005-12-13 | Appymetric, Inc. | Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA |
US5571673A (en) | 1994-11-23 | 1996-11-05 | Hoffmann-La Roche Inc. | Methods for in-solution quenching of fluorescently labeled oligonucleotide probes |
WO1996017933A2 (en) | 1994-12-09 | 1996-06-13 | Takeda Chemical Industries, Ltd. | Dna encoding a cell growth inhibiting factor and its product |
US5658730A (en) | 1994-12-23 | 1997-08-19 | Ctrc Research Foundation | Methods of human prostate cancer diagnosis |
US5728090A (en) | 1995-02-09 | 1998-03-17 | Quantum Devices, Inc. | Apparatus for irradiating living cells |
US5517313A (en) | 1995-02-21 | 1996-05-14 | Colvin, Jr.; Arthur E. | Fluorescent optical sensor |
US5556421A (en) | 1995-02-22 | 1996-09-17 | Intermedics, Inc. | Implantable medical device with enclosed physiological parameter sensors or telemetry link |
DE19506484C2 (en) | 1995-02-24 | 1999-09-16 | Stiftung Fuer Lasertechnologie | Method and device for selective non-invasive laser myography (LMG) |
US5599695A (en) | 1995-02-27 | 1997-02-04 | Affymetrix, Inc. | Printing molecular library arrays using deprotection agents solely in the vapor phase |
IT1276642B1 (en) | 1995-03-03 | 1997-11-03 | Consiglio Nazionale Ricerche | ANTI-SENSE TRANSCRIPT PRESENT IN B LYMPHOCYTES AND SYNTHETIC OLIGODEOXYNUCLEOTIDES USEFUL FOR INHIBIRING THEIR ACTION |
GB9507238D0 (en) | 1995-04-07 | 1995-05-31 | Isis Innovation | Detecting dna sequence variations |
US5624711A (en) | 1995-04-27 | 1997-04-29 | Affymax Technologies, N.V. | Derivatization of solid supports and methods for oligomer synthesis |
US5567586A (en) | 1995-05-18 | 1996-10-22 | Thomas Jefferson University | Methods of indentifying solid tumors with chromosome abnormalities in the ALL-1 region |
AU5797696A (en) | 1995-05-19 | 1996-11-29 | Ely Michael Rabani | Parallel multiplex polynucleotide sequencing |
US5690894A (en) * | 1995-05-23 | 1997-11-25 | The Regents Of The University Of California | High density array fabrication and readout method for a fiber optic biosensor |
US5571152A (en) | 1995-05-26 | 1996-11-05 | Light Sciences Limited Partnership | Microminiature illuminator for administering photodynamic therapy |
US5775331A (en) | 1995-06-07 | 1998-07-07 | Uromed Corporation | Apparatus and method for locating a nerve |
US5667974A (en) | 1995-06-07 | 1997-09-16 | Abbott Laboratories | Method for detecting nucleic acid sequences using competitive amplification |
AU716502B2 (en) | 1995-07-03 | 2000-02-24 | Aristo Medical Products, Inc. | Apparatus for determining spectral absorption |
US5661028A (en) | 1995-09-29 | 1997-08-26 | Lockheed Martin Energy Systems, Inc. | Large scale DNA microsequencing device |
US5683881A (en) | 1995-10-20 | 1997-11-04 | Biota Corp. | Method of identifying sequence in a nucleic acid target using interactive sequencing by hybridization |
US5866331A (en) | 1995-10-20 | 1999-02-02 | University Of Massachusetts | Single molecule detection by in situ hybridization |
DE19544501A1 (en) | 1995-11-29 | 1997-06-05 | Boehringer Mannheim Gmbh | Device for light reflection measurements |
US5636612A (en) * | 1995-12-20 | 1997-06-10 | Brucato; Anthony | Adjustable air velocity stacks for two-stroke fuel injected engines |
US6156502A (en) | 1995-12-21 | 2000-12-05 | Beattie; Kenneth Loren | Arbitrary sequence oligonucleotide fingerprinting |
KR100482915B1 (en) | 1996-01-23 | 2005-09-12 | 퀴아진 지노믹스, 인코포레이티드 | Methods and Compositions for Analyzing Nucleic Acid Molecules Using Size Technology |
AU2253397A (en) | 1996-01-23 | 1997-08-20 | Affymetrix, Inc. | Nucleic acid analysis techniques |
US5716784A (en) | 1996-02-05 | 1998-02-10 | The Perkin-Elmer Corporation | Fluorescence detection assay for homogeneous PCR hybridization systems |
EP0937159A4 (en) | 1996-02-08 | 2004-10-20 | Affymetrix Inc | Chip-based speciation and phenotypic characterization of microorganisms |
AU735440B2 (en) | 1996-02-09 | 2001-07-05 | Cornell Research Foundation Inc. | Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays |
US5647368A (en) | 1996-02-28 | 1997-07-15 | Xillix Technologies Corp. | Imaging system for detecting diseased tissue using native fluorsecence in the gastrointestinal and respiratory tract |
US5723294A (en) | 1996-03-05 | 1998-03-03 | Gull Laboratories | Methods for detection and discrimination of multiple analytes using fluorescent technology |
US5800478A (en) | 1996-03-07 | 1998-09-01 | Light Sciences Limited Partnership | Flexible microcircuits for internal light therapy |
GB9605381D0 (en) | 1996-03-14 | 1996-05-15 | Smithkline Beecham Plc | Novel compounds |
GB9606158D0 (en) | 1996-03-23 | 1996-05-29 | Ciba Geigy Ag | Chemical compounds |
US6458530B1 (en) | 1996-04-04 | 2002-10-01 | Affymetrix Inc. | Selecting tag nucleic acids |
EP0892808B1 (en) | 1996-04-12 | 2008-05-14 | PHRI Properties, Inc. | Detection probes, kits and assays |
DE19617940A1 (en) | 1996-04-29 | 1997-10-30 | Ihf Inst Fuer Hormon Und Fortp | Epididymis-specific receptor protein and its use |
US5928137A (en) | 1996-05-03 | 1999-07-27 | Green; Philip S. | System and method for endoscopic imaging and endosurgery |
DE19617950A1 (en) | 1996-05-04 | 1997-11-13 | Hydac Technology Gmbh | Piston accumulator with gas preload |
US5916766A (en) | 1996-05-23 | 1999-06-29 | Smithkline Beecham Corporation | Human marco scavenger receptor |
US6008014A (en) * | 1996-09-04 | 1999-12-28 | Millennium Pharmaceuticals, Inc. | Method of making lipid metabolic pathway compositions |
US5730134A (en) | 1996-09-09 | 1998-03-24 | General Electric Company | System to monitor temperature near an invasive device during magnetic resonance procedures |
US5829878A (en) | 1996-10-15 | 1998-11-03 | Micro Idea Instruments, Ltd. | Digital fever thermometer having an illuminated display |
US5696157A (en) | 1996-11-15 | 1997-12-09 | Molecular Probes, Inc. | Sulfonated derivatives of 7-aminocoumarin |
US5885293A (en) | 1997-03-03 | 1999-03-23 | Innovasive Devices, Inc. | Apparatus and method for cutting a surface at a repeatable angle |
US5935119A (en) * | 1997-08-06 | 1999-08-10 | United States Surgical Corporation | Perfusion structure |
US20010041862A1 (en) * | 1997-09-02 | 2001-11-15 | Morton G. Glickman | Novel apparatus and method of treating a tumor in the extremity of a patient |
US6289229B1 (en) | 1998-01-20 | 2001-09-11 | Scimed Life Systems, Inc. | Readable probe array for in vivo use |
US6219137B1 (en) * | 1998-12-03 | 2001-04-17 | Lockheed Martin Energy Research Corporation | Nanoprobe for surface-enhanced Raman spectroscopy in medical diagnostic and drug screening |
-
1999
- 1999-01-19 US US09/233,409 patent/US6289229B1/en not_active Expired - Lifetime
-
2001
- 2001-06-14 US US09/881,283 patent/US7302289B2/en not_active Expired - Fee Related
-
2007
- 2007-01-09 US US11/621,415 patent/US8140148B2/en not_active Expired - Fee Related
Patent Citations (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4832034A (en) * | 1987-04-09 | 1989-05-23 | Pizziconi Vincent B | Method and apparatus for withdrawing, collecting and biosensing chemical constituents from complex fluids |
US5412087A (en) * | 1992-04-24 | 1995-05-02 | Affymax Technologies N.V. | Spatially-addressable immobilization of oligonucleotides and other biological polymers on surfaces |
US5408996A (en) * | 1993-03-25 | 1995-04-25 | Salb; Jesse | System and method for localization of malignant tissue |
US5716981A (en) * | 1993-07-19 | 1998-02-10 | Angiogenesis Technologies, Inc. | Anti-angiogenic compositions and methods of use |
US6122536A (en) * | 1995-07-06 | 2000-09-19 | Animas Corporation | Implantable sensor and system for measurement and control of blood constituent levels |
US5833603A (en) * | 1996-03-13 | 1998-11-10 | Lipomatrix, Inc. | Implantable biosensing transponder |
US6343227B1 (en) * | 1996-11-21 | 2002-01-29 | Boston Scientific Corporation | Miniature spectrometer |
US6119031A (en) * | 1996-11-21 | 2000-09-12 | Boston Scientific Corporation | Miniature spectrometer |
US6201989B1 (en) * | 1997-03-13 | 2001-03-13 | Biomax Technologies Inc. | Methods and apparatus for detecting the rejection of transplanted tissue |
US6405073B1 (en) * | 1997-07-22 | 2002-06-11 | Scimed Life Systems, Inc. | Miniature spectrometer system and method |
US6238348B1 (en) * | 1997-07-22 | 2001-05-29 | Scimed Life Systems, Inc. | Miniature spectrometer system and method |
US6185443B1 (en) * | 1997-09-29 | 2001-02-06 | Boston Scientific Corporation | Visible display for an interventional device |
US6324418B1 (en) * | 1997-09-29 | 2001-11-27 | Boston Scientific Corporation | Portable tissue spectroscopy apparatus and method |
US6364831B1 (en) * | 1997-09-29 | 2002-04-02 | Boston Scientific Corporation | Endofluorescence imaging module for an endoscope |
US5984861A (en) * | 1997-09-29 | 1999-11-16 | Boston Scientific Corporation | Endofluorescence imaging module for an endoscope |
US6322495B1 (en) * | 1998-01-15 | 2001-11-27 | Scimed Life Systems, Inc. | Method for placing a feeding tube inside a gastro-intestinal tract |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070088195A1 (en) * | 2005-10-18 | 2007-04-19 | Boston Scientific Scimed, Inc. | Method of using an imaging catheter to conduct photodynamic procedures |
US7901441B2 (en) * | 2005-10-18 | 2011-03-08 | Boston Scientific Scimed, Inc. | Method of using an imaging catheter to conduct photodynamic procedures |
US10517569B2 (en) | 2012-05-09 | 2019-12-31 | The Regents Of The University Of Michigan | Linear magnetic drive transducer for ultrasound imaging |
Also Published As
Publication number | Publication date |
---|---|
US6289229B1 (en) | 2001-09-11 |
US7302289B2 (en) | 2007-11-27 |
US20070167719A1 (en) | 2007-07-19 |
US8140148B2 (en) | 2012-03-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6289229B1 (en) | Readable probe array for in vivo use | |
US5993378A (en) | Electro-optical instruments and methods for treating disease | |
US9872613B2 (en) | Monitoring disposition of tethered capsule endoscope in esophagus | |
US6738651B1 (en) | Catheter based probe and method of using same for detecting chemical analytes | |
US6296608B1 (en) | Diagnosing and performing interventional procedures on tissue in vivo | |
AU763861B2 (en) | Apparatus and method for determining tissue characteristics | |
US6324418B1 (en) | Portable tissue spectroscopy apparatus and method | |
US6055451A (en) | Apparatus and method for determining tissue characteristics | |
JP2583730B2 (en) | Sensor device | |
EP0939894B1 (en) | Miniature spectrometer | |
US6882875B1 (en) | Visible display for an interventional device | |
US20070032739A1 (en) | Device for forming an effective sensor-to-tissue contact | |
EP1092385B1 (en) | Sheathed probes for tissue type recognition | |
US20120184827A1 (en) | Miniature disease optical spectroscopy diagnostic system | |
JP2000506410A (en) | Implantable biosensing transponder | |
CA2731793A1 (en) | Real-time pathology | |
JP2010537771A (en) | Monitoring the placement of tethered capsule endoscopes in the esophagus | |
EP1704821B1 (en) | Disease change detection system | |
EP2013795A2 (en) | Device, system and method for in-vivo analysis | |
Mourant et al. | Detection of gastrointestinal cancer by elastic scattering and absorption spectroscopies with the Los Alamos Optical Biopsy System | |
Deutsch | Lasers and optics in health care | |
JP2014057898A (en) | Monitoring of esophageal arrangement of capsule endoscope with tether | |
WO2004026127A1 (en) | Improvements in or relating to neonatal sensor devices | |
Bigio et al. | Optical diagnostics based on elastic scattering: an update of clinical demonstrations with the optical biopsy system | |
CN114729888A (en) | Real-time fluorescence detection system for medical devices |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: SCIMED LIFE SYSTEMS, INC., MINNESOTA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:CROWLEY, ROBERT J.;REEL/FRAME:014069/0674 Effective date: 19990322 |
|
FEPP | Fee payment procedure |
Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
AS | Assignment |
Owner name: BOSTON SCIENTIFIC SCIMED, INC., MINNESOTA Free format text: CHANGE OF NAME;ASSIGNOR:SCIMED LIFE SYSTEMS, INC.;REEL/FRAME:018505/0868 Effective date: 20050101 Owner name: BOSTON SCIENTIFIC SCIMED, INC.,MINNESOTA Free format text: CHANGE OF NAME;ASSIGNOR:SCIMED LIFE SYSTEMS, INC.;REEL/FRAME:018505/0868 Effective date: 20050101 |
|
CC | Certificate of correction | ||
FPAY | Fee payment |
Year of fee payment: 4 |
|
REMI | Maintenance fee reminder mailed | ||
LAPS | Lapse for failure to pay maintenance fees | ||
STCH | Information on status: patent discontinuation |
Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362 |
|
FP | Lapsed due to failure to pay maintenance fee |
Effective date: 20151127 |